{"study_id": 102110, "supplement_id": 862, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of Akkermansia muciniphila as a next-generation probiotic, focusing on its growth conditions, safety, and metabolic effects in humans.", "results_summary": "The study found that Akkermansia muciniphila requires specific amino sugars for cultivation and may prevent metabolic syndrome and diabetes in mice. Initial human administration showed safety and positive metabolic effects.", "population_specificity": "Mice and humans (initial evidence).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "Prebiotics (oligosaccharides, polyphenols) and metformin may promote its growth.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:29.215145+00:00"}
{"study_id": 102113, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine whether Akkermansia muciniphila could serve as a probiotic to aid in weight management and metabolic health.", "results_summary": "The abstract does not provide specific findings regarding Akkermansia muciniphila's effects.", "population_specificity": "Not specified", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:29.530443+00:00"}
{"study_id": 102111, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Akkermansia muciniphila plays a role in nutrient absorption by evaluating stool calorie loss under dietary and pharmacological interventions.", "results_summary": "The study found that Akkermansia muciniphila increased in both dietary underfeeding and vancomycin treatment, both of which led to greater stool calorie loss, suggesting a potential role in modulating nutrient absorption.", "population_specificity": "27 volunteers (17 men, 10 women) with impaired glucose tolerance and obesity (BMI 32.3 \u00b1 8.0, age 35.1 \u00b1 7.3).", "effective_dosage": "Not specified", "study_duration": "3 days for dietary intervention; duration of vancomycin treatment not specified in abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:30.844545+00:00"}
{"study_id": 102114, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether genistein intake modifies gut microbiota, particularly increasing Verrucomicrobia (including Akkermansia muciniphila), and improves insulin resistance and metabolic markers in obese individuals.", "results_summary": "Genistein consumption increased Verrucomicrobia abundance, reduced insulin resistance, and enhanced fatty acid oxidation in skeletal muscle, leading to improved metabolic markers like \u03b2-oxidation metabolites and ketone bodies.", "population_specificity": "45 obese participants (BMI 30-40 kg/m\u00b2) with HOMA index >2.5.", "effective_dosage": "Not specified", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:31.568326+00:00"}
{"study_id": 102112, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate differences in gut microbiota composition, including Akkermansia muciniphila, between individuals with obesity and those with normal weight.", "results_summary": "The study found that individuals with obesity had lower levels of Verrucomicrobia (Akkermansia muciniphila) compared to lean individuals, suggesting a potential negative correlation between Akkermansia muciniphila and obesity.", "population_specificity": "Adults with obesity and lean individuals.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:31.700459+00:00"}
{"study_id": 102115, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to examine the effect of a low FODMAP diet on the intestinal microbiota, including Akkermansia muciniphila, and its association with inflammation and symptoms in patients with ulcerative colitis.", "results_summary": "The abstract does not provide specific results for Akkermansia muciniphila, only stating that its quantity in fecal samples would be explored alongside other microbiota and inflammatory markers.", "population_specificity": "Thirty patients with mild to moderate ulcerative colitis.", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:33.567562+00:00"}
{"study_id": 102116, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to summarize the relationship between Akkermansia muciniphila and host health, focusing on metabolic diseases and mechanisms, as well as factors affecting its colonization.", "results_summary": "The study highlights A. muciniphila's role in maintaining intestinal barrier function and its positive correlation with host metabolic homeostasis, suggesting potential benefits for metabolic diseases. It also reviews natural and drug-derived substrates influencing its colonization.", "population_specificity": "Not specified (general human health focus)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:33.572967+00:00"}
{"study_id": 102117, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the potential of Akkermansia muciniphila as a prebiotic to influence oral microbiota and its therapeutic role in metabolic diseases.", "results_summary": "The abstract suggests that Akkermansia muciniphila may serve as a novel therapeutic strategy to modulate oral microbiota, potentially impacting systemic pathologies like diabetes and metabolic disorders, though specific efficacy data are not detailed.", "population_specificity": "General discussion on oral microbiota and metabolic diseases, no specific population studied.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:35.037440+00:00"}
{"study_id": 102120, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the impact of a lifestyle intervention, including functional foods, on gut microbiota dysbiosis, specifically focusing on the abundance of Akkermansia muciniphila in subjects with metabolic syndrome.", "results_summary": "The study found that the lifestyle intervention increased the abundance of Akkermansia muciniphila, reduced gut microbiota dysbiosis, and improved metabolic parameters such as triglycerides, low-density lipoprotein cholesterol, and glucose intolerance.", "population_specificity": "Subjects with metabolic syndrome in Mexico City, Mexico.", "effective_dosage": "Not specified", "study_duration": "75 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:37.385640+00:00"}
{"study_id": 102123, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not specify a study goal related to Akkermansia muciniphila.", "results_summary": "The abstract does not provide results specific to Akkermansia muciniphila.", "population_specificity": "Not specified.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:37.595060+00:00"}
{"study_id": 102119, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Akkermansia muciniphila in maintaining intestinal homeostasis and its involvement in metabolic and gastrointestinal disorders.", "results_summary": "Akkermansia muciniphila improves intestinal barrier function and host immunological responses, with its levels inversely correlating to inflammatory conditions like obesity, diabetes, and inflammatory bowel disease. Therapeutic administration of A. muciniphila reduces the development of these disorders.", "population_specificity": "Not specified (general gut microbiota context)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:38.191272+00:00"}
{"study_id": 102124, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to summarize gut microbiota (GM) dysbiosis modification post-bariatric surgery (BS) and its link to clinical improvements, including the role of Akkermansia muciniphila.", "results_summary": "The study found that BS partially rescues GM dysbiosis observed in obesity, with some GM changes linked to beneficial outcomes like weight loss and metabolic improvements, though variability exists among patients.", "population_specificity": "Patients with severe obesity undergoing bariatric surgery.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:38.988815+00:00"}
{"study_id": 102121, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of Akkermansia muciniphila as a next-generation probiotic for reversing obesity and insulin resistance.", "results_summary": "The study found that Akkermansia muciniphila is effective in reversing obesity and insulin resistance, positioning it as a promising next-generation probiotic for metabolic disorders.", "population_specificity": "Not specified (likely animal models, given the mention of mice in related contexts).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:39.668859+00:00"}
{"study_id": 102125, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to explore the role of gut microbiota, including Akkermansia muciniphila, in the pathophysiology of multiple sclerosis (MS) and potential therapeutic interventions.", "results_summary": "The study highlights the impact of gut microbiome changes on MS, including composition, metabolism, and immune modulation, but notes that current therapeutic interventions are still crude and require further translation from other pathologies.", "population_specificity": "General autoimmune disorders, with a focus on multiple sclerosis (MS).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:41.134541+00:00"}
{"study_id": 102127, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential metabolic benefits of Akkermansia muciniphila in the context of bariatric surgery and bile acid metabolism.", "results_summary": "The abstract suggests that Akkermansia muciniphila may contribute to metabolic improvements observed after bariatric surgery, such as enhanced insulin sensitivity and glycemia, but does not provide specific data on its effects. The role of gut bacteria, including Akkermansia muciniphila, is discussed as part of broader metabolic changes post-surgery.", "population_specificity": "Patients undergoing bariatric surgery or related metabolic interventions (not explicitly specified).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:42.692872+00:00"}
{"study_id": 102128, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the potential role of beneficial/probiotic bacteria, including Akkermansia muciniphila, in modulating metabolic and inflammatory disorders.", "results_summary": "The abstract does not provide specific findings about Akkermansia muciniphila's effects, only highlighting the broader importance of probiotic bacteria in addressing inflammatory and diet-related disorders.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:43.544175+00:00"}
{"study_id": 102129, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to review the bacteriological characteristics, safety, and causal relationship of Akkermansia muciniphila with metabolic disorders, immune diseases, and cancer therapy.", "results_summary": "The study highlights A. muciniphila's potential benefits in improving host metabolic functions and immune responses, as well as its possible role in cancer treatment, but notes a lack of causal evidence and limited human intervention studies.", "population_specificity": "Not specified (abstract mentions animal experiments and limited human studies).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:45.124020+00:00"}
{"study_id": 102130, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the potential manipulation of gut microbiota, including Akkermansia muciniphila, by herbal products in obesity.", "results_summary": "Supplementation with high concentrations of polyphenols enriched the growth of Akkermansia muciniphila and inhibited detrimental species, correlating with reduced body weight gain in animal studies. However, changes in gut microbiota did not always correlate with weight loss.", "population_specificity": "Animal studies and clinical trials involving obese subjects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:45.528921+00:00"}
{"study_id": 102131, "supplement_id": 862, "safety_score": "90", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effects of fecal microbiota transfer (FMT) on IBS symptoms and explore the association between Akkermansia muciniphila abundance and pain modulation.", "results_summary": "The study found that Akkermansia muciniphila's relative abundance was inversely correlated with pain reduction in IBS patients, suggesting a potential role in pain modulation. FMT increased gut microbiota diversity and reduced abdominal pain symptoms in a subset of patients.", "population_specificity": "13 IBS patients with recurrent, treatment-refractory symptoms.", "effective_dosage": "Not specified (FMT from one healthy donor).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:46.598923+00:00"}
{"study_id": 102133, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of a high-fibre, polyphenol-rich, and vegetable-protein-based diet on faecal microbiota, including Akkermansia muciniphila, in patients with type 2 diabetes.", "results_summary": "The dietary intervention significantly increased Akkermansia muciniphila abundance, a bacterium with anti-inflammatory effects, alongside improvements in glycaemic control and lipid profiles. The changes were independent of antidiabetic drug use.", "population_specificity": "81 patients with type 2 diabetes", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:47.505942+00:00"}
{"study_id": 102132, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the association between Akkermansia muciniphila (AM) abundance and body composition, microbiota diversity, and inflammatory markers in overweight and obese female early-stage breast cancer patients.", "results_summary": "Women with high AM abundance (HAM) had lower fat mass and higher microbiota diversity at baseline compared to those with low AM (LAM). Dietary fiber intake was positively associated with AM in LAM participants, suggesting AM may mediate fiber's effects on microbiota composition.", "population_specificity": "Overweight and obese female early-stage (0 to II) breast cancer patients.", "effective_dosage": "Not specified", "study_duration": "Mean of 30\u00b19 days (from diagnosis to lumpectomy)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:48.359469+00:00"}
{"study_id": 102134, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to investigate the relationship between gut bacterial species, including Akkermansia muciniphila, and metabolic parameters and dietary intake in obese individuals.", "results_summary": "The study did not report specific findings on Akkermansia muciniphila's effects, focusing instead on C. coccoides and its correlation with dietary fat intake and metabolic markers.", "population_specificity": "34 obese subjects with and without metabolic syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:48.595436+00:00"}
{"study_id": 102136, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of Akkermansia muciniphila in enhancing anticancer immune responses and its broader health benefits.", "results_summary": "The study found that Akkermansia muciniphila is associated with favorable anticancer immune responses in preclinical models and cancer patients, and it may also improve general health by reducing metabolic disorders and chronic inflammation.", "population_specificity": "Preclinical tumor models and patients with cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:51.036655+00:00"}
{"study_id": 102135, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of Akkermansia muciniphila in colorectal carcinoma development and its potential impact on tumor response to chemotherapy and immune checkpoint inhibitors.", "results_summary": "The study highlights Akkermansia muciniphila's involvement in modulating tumor response to chemotherapeutic agents and immune checkpoint inhibitors, suggesting its potential role in colorectal carcinoma pathogenesis and treatment.", "population_specificity": "Not specified (general discussion of colorectal carcinoma and gut microbiota)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:51.549057+00:00"}
{"study_id": 102137, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to understand how metformin affects gut microbiota, particularly the growth of Akkermansia muciniphila, and its role in glucose-lowering effects in diabetes.", "results_summary": "The study found that metformin enhances the growth of Akkermansia muciniphila, improves glucose uptake, promotes SCFA production, and protects the intestinal barrier. These changes contribute to the glucose-lowering effects of metformin in diabetic patients.", "population_specificity": "Human and animal subjects with type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:53.376360+00:00"}
{"study_id": 102138, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review Akkermansia muciniphila's characteristics, its role as a key species in the mucosal microbiome, and its impact on host health.", "results_summary": "The study found that A. muciniphila enhances mucus thickness and gut barrier function, improves host metabolic markers, and produces beneficial short-chain fatty acids, contributing to host-microbiota symbiosis. It also signals host immune responses via its outer membrane components.", "population_specificity": "Not specified (general human intestinal microbiota context)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:53.913206+00:00"}
{"study_id": 102140, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of EpiCor fermentate on gut microbiome modulation, including its impact on Akkermansia muciniphila levels, in individuals with gastrointestinal discomfort and constipation.", "results_summary": "The study found a significant increase in Akkermansia muciniphila in the moderate symptom subgroup, correlating with improvements in bloating, fullness, and stool consistency. These effects were accompanied by enhanced quality of life and reduced perceived stress.", "population_specificity": "80 subjects with symptoms of gastrointestinal discomfort and constipation, stratified into severe and moderate subgroups.", "effective_dosage": "500 mg/day of EpiCor fermentate.", "study_duration": "6 weeks of intervention.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:56.566951+00:00"}
{"study_id": 102141, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to characterize the impact of azithromycin on the gut microbiota, including changes in the relative abundance of Akkermansia muciniphila.", "results_summary": "Azithromycin reduced the relative abundance of Akkermansia muciniphila, a member of the Verrucomicrobia phylum, as part of a broader shift in taxonomic composition. The study did not assess direct health outcomes related to this reduction.", "population_specificity": "6-11 month-old infants in India.", "effective_dosage": "Not specified (3-day course of azithromycin).", "study_duration": "3 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:56.568350+00:00"}
{"study_id": 102142, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to characterize the gut bacterial microbiota, including Akkermansia muciniphila, in patients with primary sclerosing cholangitis (PSC) and ulcerative colitis (UC).", "results_summary": "The study found that microbial profiles in PSC and UC were characterized by low bacterial diversity and significant changes in global microbial composition, but it did not specifically detail the effects of Akkermansia muciniphila.", "population_specificity": "106 study participants, including 43 PSC patients with UC.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:57.391708+00:00"}
{"study_id": 102139, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to identify fecal microbial signatures, including Akkermansia muciniphila, that distinguish children with atopic dermatitis (AD) who have food allergies from those who do not.", "results_summary": "Akkermansia muciniphila was one of six bacterial species identified in a combined microbial signature that effectively discriminated between children with AD who had food allergies and those who did not (AUC 0.83, sensitivity 0.77, specificity 0.80). The study suggests a potential association between Akkermansia muciniphila and food allergy status in this population.", "population_specificity": "Pediatric patients with atopic dermatitis (median age 2.5 years), some with food allergies (n=20) and some without.", "effective_dosage": "Not available", "study_duration": "Not specified (cross-sectional observational study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:57.452814+00:00"}
{"study_id": 102143, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the influence of gut microbiota, including Akkermansia muciniphila, on intestinal wound healing mechanisms.", "results_summary": "The abstract suggests that gut microbes, potentially including Akkermansia muciniphila, influence intestinal healing through ROS production and FPR activation, but specific findings about Akkermansia muciniphila are not detailed.", "population_specificity": "Not specified", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:58.119272+00:00"}
{"study_id": 102144, "supplement_id": 862, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to determine the mechanisms behind Akkermansia muciniphila's protective effects against obesity and diabetes, and to assess its safety and efficacy in humans.", "results_summary": "The study found that Akkermansia muciniphila, especially when pasteurized, reduced fat mass, insulin resistance, and dyslipidemia in mice, and identified a specific protein (Amuc_1100) that partly replicates these benefits. It also demonstrated safety in humans when grown on a synthetic medium.", "population_specificity": "Mice and humans (safety assessment).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:59.824218+00:00"}
{"study_id": 102146, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential of Akkermansia muciniphila in restoring intestinal microbiota and its therapeutic role in selected diseases.", "results_summary": "The study highlights Akkermansia muciniphila's ability to degrade mucin and produce beneficial metabolites like acetic acid, propionic acid, and oligosaccharides, which support gut health and inhibit inflammation. It also suggests its promising role in obesity and diabetes, though efficacy in other diseases remains under investigation.", "population_specificity": "Not specified (general discussion on gastrointestinal diseases, obesity, diabetes, and other metabolic conditions).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:02.255181+00:00"}
{"study_id": 102147, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the potential role of Akkermansia muciniphila in metabolic health and its association with lean individuals compared to overweight or metabolically unhealthy individuals.", "results_summary": "The study found that Akkermansia muciniphila is more prevalent in lean individuals and may be linked to improved metabolic health, though causality in humans remains unproven. Probiotics, including Akkermansia muciniphila, show promise in improving glucose metabolism and insulin sensitivity, but evidence for weight management is limited.", "population_specificity": "Lean and overweight or metabolically unhealthy individuals (cross-sectional human studies and animal models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:05.091347+00:00"}
{"study_id": 102148, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the association between Akkermansia muciniphila abundance, gut microbiome gene richness, diet, host characteristics, and their changes after calorie restriction in overweight and obese adults.", "results_summary": "Higher baseline A. muciniphila abundance was associated with a healthier metabolic status (e.g., lower fasting glucose, better fat distribution) and greater improvements in insulin sensitivity after calorie restriction. Participants with higher baseline A. muciniphila maintained higher levels post-intervention compared to those with lower baseline levels.", "population_specificity": "Overweight and obese adults (N=49, 41 women).", "effective_dosage": "Not specified", "study_duration": "6-week calorie restriction followed by 6-week weight stabilization.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:05.150895+00:00"}
{"study_id": 102149, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to review studies since 2007 to assess the role of intestinal microbiota, including Akkermansia muciniphila, in allergic diseases.", "results_summary": "The study found that allergic children had lower counts of Akkermansia muciniphila in their microbiota at the onset of allergic symptoms, suggesting a potential protective role. No direct intervention or efficacy of supplementation was assessed.", "population_specificity": "Children with allergic diseases and early microbiota analysis.", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:05.261643+00:00"}
{"study_id": 102150, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to compare gut fermentation and microbiota composition, including Akkermansia muciniphila levels, between UC patients in remission and healthy controls under habitual and increased dietary fiber conditions.", "results_summary": "The study found that UC patients had lower proportions of Akkermansia muciniphila compared to controls, but increasing resistant starch and wheat bran intake did not significantly alter its levels or fermentation patterns. The microbiota in UC patients also showed increased diversity within Clostridium cluster XIVa.", "population_specificity": "Patients with ulcerative colitis (UC) in remission and matched healthy controls.", "effective_dosage": "Not specified (increased intake of wheat bran-associated fiber and high amylose-associated resistant starch).", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:06.598187+00:00"}
{"study_id": 102151, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Akkermansia muciniphila in improving metabolic parameters in obesity and nonalcoholic fatty liver disease (NAFLD) by modulating gut microbiota and reducing gut permeability.", "results_summary": "The study found that a decrease in Akkermansia muciniphila is linked to thinner intestinal mucus layers and increased gut permeability, while interventions to increase its abundance improved metabolic parameters in obesity and NAFLD.", "population_specificity": "Individuals with obesity and NAFLD (specific age or demographic details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:06.785779+00:00"}
{"study_id": 102152, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the association between Akkermansia muciniphila and type 2 diabetes (T2D), including its potential antidiabetic effects.", "results_summary": "The study found that Akkermansia muciniphila might be decreased in diabetes and that its administration exerted antidiabetic effects in murine models. The abstract suggests a potential role for Akkermansia muciniphila in modulating metabolic health.", "population_specificity": "Murine models and humans with type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:07.316157+00:00"}
{"study_id": 102153, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify microbial species, including Akkermansia muciniphila, that correlate with health and disease, particularly in metabolic conditions.", "results_summary": "The study found that Akkermansia muciniphila is associated with health benefits, particularly in metabolic diseases, and its presence correlates with improved metabolic health markers. It influences host-microbe interactions through metabolites and bile acid modulation.", "population_specificity": "General human microbiota in metabolic disease contexts (e.g., diabetes, obesity, cardiovascular disease).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:10.696863+00:00"}
{"study_id": 102145, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize existing data on the intestinal distribution of Akkermansia muciniphila in health and disease, explore its ecological role, and discuss its regulatory effects on host functions in metabolic disorders.", "results_summary": "The study found that Akkermansia muciniphila is associated with health benefits, with reduced levels observed in inflammatory bowel diseases and metabolic disorders, suggesting potential anti-inflammatory properties. It plays a key role in microbial networks at the mucosal interface and may regulate host functions disrupted in diseases.", "population_specificity": "Humans and animals (general, with specific mention of patients with inflammatory bowel diseases and metabolic disorders).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:11.851804+00:00"}
{"study_id": 102154, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of Akkermansia muciniphila as a next-generation probiotic for inflammatory and diet-related disorders.", "results_summary": "Preclinical trials showed promising results for Akkermansia muciniphila in addressing inflammatory and diet-related disorders, though its effectiveness in humans at a population level or in personalized nutrition remains unexplored.", "population_specificity": "Preclinical trials (not specified if human or animal).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:12.926363+00:00"}
{"study_id": 102155, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to compare the quantities of Akkermansia muciniphila and other bacteria in mucosal and faecal samples to assess their distribution and detectability.", "results_summary": "Akkermansia muciniphila was detected at higher levels in faecal samples compared to mucosal samples, with no significant difference between mucosal sites (right vs. left colon). The study did not evaluate its functional effects or health outcomes.", "population_specificity": "20 patients with endoscopically and histologically normal mucosa undergoing diagnostic colonoscopy.", "effective_dosage": "Not available", "study_duration": "Not applicable (observational study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:13.110991+00:00"}
{"study_id": 201647, "supplement_id": 862, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the bacteriological characteristics of Akkermansia muciniphila, factors influencing its abundance in the gut, and its potential probiotic use in alcohol-related liver diseases.", "results_summary": "The study found that Akkermansia muciniphila supplementation can improve ethanol-related liver pathologies, suggesting its potential as a probiotic. Lower levels of A. muciniphila were associated with obesity, diabetes, metabolic syndromes, and inflammatory digestive diseases.", "population_specificity": "Individuals with alcohol-related liver diseases (e.g., alcoholic hepatitis, cirrhosis, hepatocellular carcinoma) and metabolic disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:13.524290+00:00"}
{"study_id": 321, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the therapeutic effects of Ala-Gln on diabetic retinal neurodegeneration and its mechanism of action.", "results_summary": "Ala-Gln restored declined ERG amplitudes, reduced retinal inflammation, improved mitochondrial function, and enhanced glucose metabolism in diabetic rats. It also mitigated declines in glutamine synthetase and ameliorated upregulated GFAP levels.", "population_specificity": "Streptozotocin-induced diabetic rats.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:14.751947+00:00"}
{"study_id": 323, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine if pyrrolysine tRNA (tRNAPyl) could serve as a scaffold for developing suppressor tRNAs (PASS-tRNAs) to restore protein synthesis from genes with premature termination codons (PTCs).", "results_summary": "PASS-tRNAs restored protein synthesis to wild-type levels in bacterial cells and showed robust PTC suppression in human cells, including pathogenic mutations in BRCA1, with high codon specificity and no cellular dysregulation.", "population_specificity": "Bacterial and human cells (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:15.607546+00:00"}
{"study_id": 324, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the correlation between the ALT/HDL-C ratio in early pregnancy and the risk of gestational diabetes mellitus (GDM).", "results_summary": "The study found a non-linear positive correlation between the ALT/HDL-C ratio and GDM risk, with a turning point at 5.51. The ALT/HDL-C ratio, when combined with maternal characteristics and metabolic indicators, improved GDM prediction sensitivity (67.6%) and specificity (87.3%).", "population_specificity": "590 single pregnant women in Korea up to 14 weeks gestation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:17.831316+00:00"}
{"study_id": 325, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the causal relationship between the phosphate-to-alanine ratio and the risk of upper gastrointestinal cancers (esophageal and gastric cancer) using Mendelian randomization analysis.", "results_summary": "The study found a significant causal relationship between the phosphate-to-alanine ratio and an increased risk of upper gastrointestinal cancers, suggesting it may serve as a potential biomarker or therapeutic target. No direct adverse effects or safety concerns regarding alanine were reported.", "population_specificity": "Patients with upper gastrointestinal cancers (esophageal and gastric cancer) based on GWAS datasets.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:21.693137+00:00"}
{"study_id": 326, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to test the association between low alanine aminotransferase (ALT) levels, as a biomarker for sarcopenia, and shorter survival in renal cell carcinoma (RCC) patients and survivors.", "results_summary": "Low ALT levels (<17 IU/L) were significantly associated with increased mortality (72% higher in univariate analysis, 27% higher in multivariate analysis) in RCC patients, indicating a potential link between sarcopenia, frailty, and poorer survival outcomes.", "population_specificity": "Renal cell carcinoma (RCC) patients and survivors, including in- and outpatients (mean age 65.6 \u00b1 13.3 years, 68% male).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:23.559731+00:00"}
{"study_id": 328, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the benefits of antiviral therapy versus regular examination in HBeAg-negative chronic hepatitis B patients with normal alanine transaminase (ALT) and positive HBV DNA after nucleos(t)ide analogs (NAs) treatment.", "results_summary": "The study is ongoing, so no results are reported yet; it focuses on virological response, serum HBV pregenomic RNA levels, and health-related quality of life.", "population_specificity": "HBeAg-negative chronic hepatitis B patients with normal ALT, including inactive carriers and those in the grey zone.", "effective_dosage": "Not specified", "study_duration": "96 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:24.315789+00:00"}
{"study_id": 327, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess liver histological changes in patients with chronic hepatitis B (CHB) who had persistently normal alanine aminotransferase (ALT) levels and to determine associations between significant liver injury and clinical parameters.", "results_summary": "The study found that a substantial proportion of HBV-infected patients with normal ALT levels had significant liver injury. HBsAg and AST levels were predictive of inflammation, while HBV DNA load and age were predictive of fibrosis in HBeAg-positive patients. In HBeAg-negative patients, HBV DNA and AST levels predicted inflammation, and AST levels predicted fibrosis.", "population_specificity": "Treatment-na\u00efve patients with chronic HBV infections (HBeAg-positive and HBeAg-negative) who had persistently normal ALT levels.", "effective_dosage": "Not specified", "study_duration": "Retrospective study spanning 2013 to 2023", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:24.788632+00:00"}
{"study_id": 330, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the effects and mechanisms of the MANS peptide (containing alanine) on SH-SY5Y human neuroblastoma cells as a model for neuronal differentiation.", "results_summary": "MANS peptide treatment significantly induced neurite outgrowth within 24 hours, comparable to all-trans retinoic acid, increased synaptophysin levels, and altered MARCKS levels and phosphorylation. MARCKS knockdown reduced neurite outgrowth, suggesting MANS peptide's role in neuronal differentiation.", "population_specificity": "SH-SY5Y human neuroblastoma cells (in vitro model).", "effective_dosage": "Not specified.", "study_duration": "24 hours (for neurite outgrowth assessment).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:25.298497+00:00"}
{"study_id": 331, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess the anti-inflammatory properties of a bioactive glutamic-alanine rich glycoprotein (GP) derived from Undaria pinnatifida in vitro and in vivo.", "results_summary": "GP reduced the expression of iNOS and COX-2, inhibited NO and PGE2 production, and blocked NF-\u03baB and MAPK pathways, leading to reduced inflammation in both cell models and mouse models of carrageenan- and xylene-induced inflammation.", "population_specificity": "LPS-stimulated RAW264.7 cells, peritoneal macrophages, and mouse models of inflammation.", "effective_dosage": "10 mg/kg/day (p.o.)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:25.620701+00:00"}
{"study_id": 332, "supplement_id": 863, "safety_score": "80", "efficacy_score": 20, "quality_score": 70, "study_goal": "The researchers aimed to investigate the effect of \u03b2-alanine (BA) on laser-induced choroidal neovascularization (CNV) in mice models, focusing on its potential impact on age-related macular degeneration (AMD).", "results_summary": "BA treatment increased CNV lesion areas in mice, suggesting detrimental effects for AMD. No significant hepatorenal toxicity was observed in liver and kidney sections.", "population_specificity": "Laser-induced CNV mice models.", "effective_dosage": "Not specified.", "study_duration": "One week and two weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:25.845386+00:00"}
{"study_id": 329, "supplement_id": 863, "safety_score": "40", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to assess the effect of high-dose multivitamins on alanine aminotransferase (ALT) elevations and identify subgroups of people living with HIV/AIDS (PLWHA) at greater risk of hepatotoxicity.", "results_summary": "High-dose multivitamins increased the risk of mild/moderate ALT elevations (>40 IU/L) but had no overall effect on severe ALT elevations (>200 IU/L). Immunocompromised individuals with CD4 T-cell counts \u2264100 cells/\u00b5L had a higher risk of severe ALT elevations with high-dose multivitamins.", "population_specificity": "Adults initiating antiretroviral therapy (ART) in Tanzania.", "effective_dosage": "High-dose multivitamins containing vitamin B complex, vitamin C, and vitamin E at multiple recommended dietary allowances (RDAs) vs. standard-dose multivitamins at single RDAs.", "study_duration": "2006-2009 (exact duration not specified in abstract).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:26.128509+00:00"}
{"study_id": 334, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether dietary \u03b2-alanine could improve growth, intestinal immune responses, and gut barrier function in broiler chickens infected with Eimeria maxima.", "results_summary": "\u03b2-alanine reduced proinflammatory cytokine expression in chicken macrophages, improved gut integrity markers (occludin and JAM-2), and increased body weight in infected broilers. Dietary \u03b2-alanine showed positive effects on intestinal immune responses and barrier function.", "population_specificity": "Broiler chickens infected with Eimeria maxima.", "effective_dosage": "Not specified (referred to as \"H-ALA group\").", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:29.666883+00:00"}
{"study_id": 335, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to elucidate the structure-activity relationship of FRATtide-derived peptides, including those modified via alanine scanning, to identify potent derivatives for osteoporosis treatment.", "results_summary": "Substitutions with alanine in specific residues reduced activity, while other modifications (Gly13 and Arg21) enhanced osteoclast differentiation inhibition and bone resorption. FRT13 and FRT20 showed superior efficacy compared to FRATtide.", "population_specificity": "Not specified (in vitro study, likely osteoclast models).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:31.631470+00:00"}
{"study_id": 337, "supplement_id": 863, "safety_score": "30", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to investigate the mechanism by which DGAT1 inhibition, in combination with corn oil loading, affects intestinal morphology and permeability, leading to increased plasma ALT and AST levels.", "results_summary": "The study found that DGAT1 inhibition with corn oil loading caused shedding of intestinal villi tips and increased intestinal permeability, leading to leakage of ALT and AST into the blood. These changes were linked to PKC activation.", "population_specificity": "Corn oil-loaded rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Corn oil loading", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:32.773355+00:00"}
{"study_id": 340, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the impact of Beta-Alanine supplementation combined with short sprint interval training on cardiorespiratory fitness, anaerobic power, and bio-motor abilities in volleyball players.", "results_summary": "Both groups improved significantly in all measured variables, but Beta-Alanine supplementation led to more significant enhancements in vertical and horizontal jumps compared to placebo, and it promoted uniform adaptive changes among individuals.", "population_specificity": "Young male volleyball players", "effective_dosage": "4.8 g daily", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:33.196103+00:00"}
{"study_id": 336, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the formation pathway and mechanism of pyrazines during the thermal treatment of alanine-xylose Amadori compound (Ala-ARP) and exogenous alanine (Ala), focusing on nitrogen sources and contributions to pyrazine formation.", "results_summary": "The study found that exogenous alanine preferentially captures glyoxal (GO) to form pyrazine, with lower activation energy required compared to alanine-methylglyoxal (MGO) reactions. The interaction between exogenous alanine and GO accelerated the thermal degradation of Ala-ARP, promoting the release of regenerated alanine and MGO, which intensified the formation of methylpyrazine and 2,5-dimethylpyrazine.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "30 minutes at 120 \u00b0C", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:33.605248+00:00"}
{"study_id": 338, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether lowering the upper limit of normal for alanine aminotransferase (ALT) could better identify fibrosis in metabolic-dysfunction associated fatty liver disease (MAFLD).", "results_summary": "The study found that 83.12% of MAFLD patients had normal ALT levels, suggesting current thresholds may miss cases. Lowering ALT limits could help early identification but lacks cost-effectiveness and standardized laboratory definitions.", "population_specificity": "Patients with metabolic-dysfunction associated fatty liver disease (MAFLD) and obesity.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:33.611800+00:00"}
{"study_id": 339, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the long-term implications of high-normal alanine transaminase (ALT) levels and their association with the development of metabolic dysfunction-associated fatty liver disease (MAFLD).", "results_summary": "The study found that persistently elevated, yet high-normal ALT levels are linked to an increased cumulative risk of developing MAFLD, suggesting the need for closer monitoring and potential intervention in such cases.", "population_specificity": "Individuals with high-normal ALT levels, likely adults given the context of MAFLD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:34.147069+00:00"}
{"study_id": 341, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the utility of blood biomarkers, including alanine aminotransferase (ALT), for early detection and monitoring of metabolic dysfunction-associated fatty liver disease (MAFLD).", "results_summary": "The study suggests that analyzing cumulative effects of excess high-normal blood ALT levels could help identify at-risk MAFLD patients who might not be detected through conventional imaging methods, potentially improving early detection and management.", "population_specificity": "Individuals at risk for MAFLD, including those with overweight/obesity, type 2 diabetes mellitus, or metabolic dysregulation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:34.455085+00:00"}
{"study_id": 342, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the predictive value of the AST/ALT ratio (De Ritis ratio) for recurrence and progression in non-muscle-invasive bladder cancer (NMIBC).", "results_summary": "The study found that a De Ritis ratio \u2265 1.19 was a significant predictor of tumor recurrence, while a ratio \u2265 1.21 was a risk factor for tumor progression. The ratio showed significant differences in recurrence-free and progression-free survival between high and low groups.", "population_specificity": "231 patients with NMIBC who underwent transurethral tumor resection between 2016 and 2022.", "effective_dosage": "Not specified", "study_duration": "Retrospective analysis (no intervention duration specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:39.111213+00:00"}
{"study_id": 344, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the molecular determinants of Chem-KVL, including the role of alanine substitutions, and whether staple-modified Chem-KVL would improve antibacterial activity and protease stability or decrease cytotoxicity.", "results_summary": "Ala scanning identified positively charged and hydrophobic residues as critical for Chem-KVL's antibacterial activity. Chem-A4 showed remarkable inhibition of bacterial growth, and stapled peptides SCL-4 and SCL-7 exhibited significantly higher antibacterial activity and increased helicity and stability compared to the linear peptide.", "population_specificity": "Not specified (in vitro study on bacterial strains)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:40.293290+00:00"}
{"study_id": 345, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate alterations in laboratory parameters, including alanine aminotransferase (ALT), during isotretinoin therapy for acne treatment.", "results_summary": "The study found significant elevations in ALT levels (p<0.001) during isotretinoin treatment, with a small percentage of patients exhibiting grade 1 elevations. GGT levels remained unaffected, suggesting it may be a more reliable liver function marker.", "population_specificity": "136 patients aged 18-41 undergoing isotretinoin treatment for acne.", "effective_dosage": "0.3-0.5 mg/kg/day", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:41.032188+00:00"}
{"study_id": 343, "supplement_id": 863, "safety_score": "85", "efficacy_score": 90, "quality_score": 92, "study_goal": "The researchers aimed to evaluate the 5-year efficacy and safety of tenofovir alafenamide (TAF) compared to tenofovir disoproxil fumarate (TDF) in Chinese chronic hepatitis B patients, focusing on viral suppression, alanine aminotransferase normalization, and renal/bone safety.", "results_summary": "TAF demonstrated high and sustained efficacy over 5 years, with viral suppression rates similar to TDF followed by TAF. Alanine aminotransferase normalization and serological responses were higher in the TAF-TAF group, and renal/bone safety improved after switching from TDF to TAF.", "population_specificity": "Chinese chronic hepatitis B patients", "effective_dosage": "25 mg once daily", "study_duration": "5 years (240 weeks)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:41.251835+00:00"}
{"study_id": 348, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the structure-activity relationship (SAR) of teriparatide by systematically replacing its residues with alanine to identify key residues for anti-osteoporosis activity.", "results_summary": "Alanine replacement at Gly12, His14, Ser17, Arg20, and Leu24 significantly decreased anti-osteoporosis activity, while replacement at Gly13 and Gln30 increased activity, suggesting these residues could be modified to enhance efficacy.", "population_specificity": "Not specified (in vitro or preclinical study implied).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:41.261198+00:00"}
{"study_id": 349, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether high normal ALT thresholds (male >30 or female >19 and male >29 or female >15) are better predictors of histological disease and antiviral therapy benefit in CHB patients compared to the conventional 40U/L threshold.", "results_summary": "The study found that patients with high normal ALT levels had significant histological disease at baseline and better HBV DNA clearance from antiviral treatment. High normal ALT was an independent predictor of treatment benefit, with both proposed thresholds showing higher AUC compared to current scoring systems.", "population_specificity": "1352 patients with CHB who underwent liver biopsy from 2017 to 2021.", "effective_dosage": "Not specified", "study_duration": "1-year follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:42.210305+00:00"}
{"study_id": 347, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of \u03b2-alanine metabolism-related genes (\u03b2AMRGs) in hepatocellular carcinoma (HCC) progression and prognosis.", "results_summary": "The study found that \u03b2-alanine metabolism is significantly involved in HCC pathophysiology, with higher \u03b2AMRGs scores correlating with better prognosis. It also identified EHHADH as a protective protein in HCC, downregulated in tumors and linked to tumor staging, grading, and prognosis.", "population_specificity": "Patients with hepatocellular carcinoma (HCC).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:42.241664+00:00"}
{"study_id": 346, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to describe the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in burn injury patients.", "results_summary": "The study found elevated levels of ALT and AST in most burn injury cases, particularly in men aged 45, with electrical burns, and during the first week of injury onset. Elevated enzyme levels suggest hepatocyte metabolism disruption in burn cases.", "population_specificity": "Burn injury patients (n=116) treated at Dr. Hasan Sadikin Hospital Bandung from August 2017 to July 2019.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:42.299066+00:00"}
{"study_id": 350, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the correlation between liver histology, age, and ALT levels in CHB patients, particularly focusing on those with persistently normal ALT or aged <30 years.", "results_summary": "The study found that a significant proportion of CHB patients with persistently normal ALT levels, including those under 30, exhibited notable liver inflammation and fibrosis. Higher ALT levels and lower PLT counts were independently associated with significant liver damage.", "population_specificity": "Treatment-naive chronic hepatitis B (CHB) patients, including HBeAg-positive and HBeAg-negative subgroups.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:47.129360+00:00"}
{"study_id": 351, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the performance of novel biomarkers, including Alanine transaminase (ALT), in detecting drug-induced liver injury (DILI) during therapeutic paracetamol use.", "results_summary": "ALT increased in 45% of participants on paracetamol, and biomarkers K18, miR-122, and GLDH were elevated at peak ALT. K18 showed the highest sensitivity for early DILI detection compared to ALT, miR-122, or GLDH.", "population_specificity": "110 individuals in a randomized, double-blind, placebo-controlled, crossover study.", "effective_dosage": "1 g paracetamol 4 times daily.", "study_duration": "2 weeks per treatment arm with a 2-week washout.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:48.941212+00:00"}
{"study_id": 352, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the connection between the ALT/HDL-C ratio and the risk of nonalcoholic fatty liver disease (NAFLD) in lean Chinese individuals.", "results_summary": "The study found a positive, nonlinear association between the ALT/HDL-C ratio and NAFLD risk, with an inflection point at 12.963. Higher ALT/HDL-C ratios below this threshold were significantly linked to increased NAFLD risk, particularly in individuals with BMI < 24 kg/m\u00b2 and DBP < 90 mmHg.", "population_specificity": "Lean (non-obese) Chinese individuals (average age 43.3 \u00b1 14.9 years, 45.3% women).", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 24.967 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:49.618340+00:00"}
{"study_id": 354, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine how exogenous alanine affects the formation of 2-furfural during the thermal degradation of the Amadori rearrangement product (ARP).", "results_summary": "Exogenous alanine inhibited 2-furfural generation by accelerating the interaction between ARP and 3-deoxyxylosone, blocking endogenous alanine recovery and reducing pyrazine formation. This interference diminished 2-furfural yield during ARP degradation.", "population_specificity": "Not applicable (in vitro study using chemical models).", "effective_dosage": "Not specified.", "study_duration": "Not specified (thermal treatment duration not detailed).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:49.799411+00:00"}
{"study_id": 357, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of D-alanine in the proliferation, apoptosis, and differentiation of osteoclasts, particularly its potential therapeutic effects on bone-resorptive diseases.", "results_summary": "D-alanine significantly inhibited the proliferation and differentiation of osteoclast precursors (BMMs), activated apoptosis, and reduced the expression of osteoclastogenic genes and proteins, as well as inhibited p38 and ERK1/2 signaling pathways.", "population_specificity": "Mouse bone marrow-derived macrophages (BMMs)", "effective_dosage": "Dose-dependent (specific amounts not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:49.874589+00:00"}
{"study_id": 355, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the relationship between alanine aminotransferase (ALT) trajectories within 15 days of initial antituberculosis treatment and the risk of antituberculosis drug-induced liver injury (ATLI).", "results_summary": "The study found that different ALT trajectories within 15 days of initial treatment were associated with varying risks of ATLI, with higher trajectories correlating with increased ATLI incidence. The adjusted odds ratios showed a significant increasing trend in ATLI risk with higher ALT trajectories.", "population_specificity": "Patients hospitalized for antituberculosis treatment.", "effective_dosage": "Not specified", "study_duration": "15 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:50.375171+00:00"}
{"study_id": 353, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate noninvasive models, including APGA, for assessing liver inflammation and fibrosis in CHB patients with normal or mildly elevated ALT levels.", "results_summary": "The APGA model demonstrated superior performance in evaluating significant and advanced fibrosis (AUROCs = 0.750 and 0.832) and liver inflammation (AUROCs = 0.779 and 0.874 for stages G \u2265 2 and G \u2265 3). It consistently outperformed 54 other models across patient subgroups.", "population_specificity": "Chinese patients with chronic hepatitis B (CHB) and normal or mildly elevated alanine transaminase (ALT) levels.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:51.468343+00:00"}
{"study_id": 356, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the proportion of significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal ALT and identify noninvasive predictors for such histopathology.", "results_summary": "The study found that 42.3% of patients had significant liver necroinflammation and 45.8% had significant fibrosis, despite normal ALT levels. High normal ALT, high HBV DNA, low prealbumin, and high FIB-4 were identified as independent predictors for these conditions.", "population_specificity": "HBeAg-negative chronic HBV-infected patients with normal ALT levels (n=201).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:51.528337+00:00"}
{"study_id": 358, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to understand how vancomycin interacts with modified D-alanine-D-serine motifs in vancomycin-resistant enterococci (VRE) compared to the native D-alanine-D-alanine motif.", "results_summary": "The study found that vancomycin binds to D-alanine-D-serine in a similar position and pose as the native D-alanine-D-alanine motif, but the serine-containing ligand is slightly less accommodated, contributing to reduced binding affinity. The structure also revealed unfavorable entropic effects due to locked hydroxyl conformations.", "population_specificity": "Not specified (structural study of bacterial resistance mechanisms).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:56.646336+00:00"}
{"study_id": 359, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of immunocompetence, particularly Treg levels, in assessing liver fibrosis risk in chronic hepatitis B patients with normal alanine transaminase (ALT) levels.", "results_summary": "The study found that age and Treg levels are independent risk factors for progressive liver fibrosis, with Treg > 6.81 serving as a cutoff for timely antiviral treatment. FIB-4 was negatively correlated with HBsAg and positively with age, while LSM showed a non-significant negative correlation with Treg.", "population_specificity": "57 chronic hepatitis B patients with normal ALT levels and negative HBeAg, never treated with antiviral therapy.", "effective_dosage": "Not specified", "study_duration": "Data collected from December 2020 to December 2022 (exact intervention duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:58.312105+00:00"}
{"study_id": 362, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the anticancer effects of chemically modified miRNA143-3p (CM-miR-143) lipoplexes, which target myristoylated alanine-rich C kinase, in a mouse model of colorectal cancer pelvic recurrence.", "results_summary": "CM-miR-143 lipoplexes accumulated heavily in pelvic CRC tumors with high blood flow, significantly suppressing tumor growth and improving animal survival by relieving lethal bowel obstruction caused by rectal compression. Protein analysis identified myristoylated alanine-rich C kinase as a novel target of CM-miR-143.", "population_specificity": "Mouse model bearing pelvic colorectal cancer adjacent to the rectum.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:58.524097+00:00"}
{"study_id": 360, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to understand how the whiB7 stress response in mycobacteria senses amino acid starvation, particularly alanine, and coordinates an adaptive response.", "results_summary": "The study found that whiB7 expression is regulated by the amino acid composition of a 5' regulatory uORF, enabling it to sense amino acid starvation. Specifically, whiB7 coordinates an adaptive response to alanine starvation through a feedback loop with the alanine biosynthetic enzyme, aspC.", "population_specificity": "Pathogenic mycobacteria (not human subjects).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:58.687818+00:00"}
{"study_id": 363, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the relationship between low alanine aminotransferase (ALT) levels, indicative of sarcopenia and frailty, and survival outcomes in bladder cancer patients and survivors.", "results_summary": "Low ALT levels (<17 IU/L) were associated with increased mortality (45% higher in univariate analysis, 22% higher in multivariate analysis) in bladder cancer patients, suggesting a link between sarcopenia, frailty, and poorer survival outcomes.", "population_specificity": "Bladder cancer patients and survivors (mean age 73.2 \u00b1 12 years, 80% male).", "effective_dosage": "Not applicable (ALT levels were measured, not administered).", "study_duration": "Retrospective study (no intervention duration specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:58.821341+00:00"}
{"study_id": 364, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the long-term outcomes of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal alanine transaminase levels.", "results_summary": "Continuous antiviral treatment achieved 100% virological response, significantly reduced liver fibrosis markers (APRI and FIB-4), and lowered the risks of liver nodules, cirrhosis, and hepatocellular carcinoma compared to untreated or treatment-discontinued groups. No HCC cases occurred in the treatment-adherent group.", "population_specificity": "HBeAg-negative chronic hepatitis B patients with normal alanine transaminase and positive HBV DNA (\u226520 IU/mL).", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 54 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:59.897279+00:00"}
{"study_id": 365, "supplement_id": 863, "safety_score": "20", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to detect and quantify the neurotoxin \u03b2-N-Methylamino-L-alanine (BMAA) in Cycas sphaerica seeds and evaluate the effectiveness of traditional cold water treatment in reducing BMAA content.", "results_summary": "BMAA was detected in the endosperm of C. sphaerica seeds but not in leaves or pith. Cold water washing for 48 hours reduced BMAA content by 86%, validating the traditional method but suggesting an extended treatment period for better efficacy.", "population_specificity": "Cycas sphaerica seeds (plant material, not human subjects).", "effective_dosage": "Not applicable (study focused on detection and removal methods).", "study_duration": "48 hours of cold water washing.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:00.254137+00:00"}
{"study_id": 367, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether d-alanine affects the circadian clock and glucose metabolism in the kidney, potentially offering therapeutic benefits for diabetes and circadian rhythm disorders.", "results_summary": "The study found that d-alanine exhibits a circadian rhythm, regulates gluconeogenesis in the kidney, and adjusts the circadian clock. It induced glucose production in kidney cells but not liver cells and normalized circadian behavior under constant darkness.", "population_specificity": "Mice and primary cultures of kidney proximal tubular cells from mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:05.840931+00:00"}
{"study_id": 366, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of low-molecular-weight fish collagen (LMWCP), which contains alanine, on chondrocyte protection and osteoarthritis progression in vitro and in vivo.", "results_summary": "LMWCP treatment prevented chondrocyte death, reduced matrix degradation, increased beneficial proteins (aggrecan, collagen types I and II, TIMP-1, TIMP-3), and decreased catabolic factors (phosphorylation of Smad, MMP-3, MMP-13), while suppressing inflammation and apoptosis pathways.", "population_specificity": "Primary chondrocytes (in vitro) and MIA-induced osteoarthritis rat models (in vivo).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:06.372029+00:00"}
{"study_id": 369, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether substituting interfacial residues with alanine could improve the thermal stability of protein oligomers, using chloramphenicol acetyltransferase (CAT) as a model.", "results_summary": "Substituting interfacial residues with alanine identified six critical residues for oligomer stability. Site saturation mutagenesis on these residues showed that 15% of mutations improved thermal stability by over 0.5\u00b0C without disrupting CAT activity, with certain combinations further enhancing stability.", "population_specificity": "In vitro study using the trimeric protein chloramphenicol acetyltransferase (CAT).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:06.503483+00:00"}
{"study_id": 370, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the frequency and predictors of postpartum ALT flares in mothers with chronic hepatitis B, including subgroup analysis based on HBeAg status, and to define the normal range of postpartum ALT levels in healthy mothers.", "results_summary": "The study did not report specific findings about Alanine's effects, as it focused on ALT flare patterns and predictors in mothers with chronic hepatitis B, rather than evaluating Alanine itself.", "population_specificity": "HBsAg-positive mothers (n=120) and healthy mothers without HBV infection (n=240).", "effective_dosage": "Not available", "study_duration": "Follow-up until postpartum week 24.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:06.980319+00:00"}
{"study_id": 368, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of elevated ALT levels in the development of type 2 diabetes mellitus (T2DM) in non-diabetic obese subjects receiving routine medical treatment.", "results_summary": "Elevated ALT levels were significantly associated with incident T2DM, particularly in the highest ALT quartile. Traditional risk factors like triglyceride-glucose index, age, and metabolic syndrome also contributed to T2DM risk.", "population_specificity": "Non-diabetic obese subjects (296 men and 709 women, aged 45.7 \u00b1 13.12 years, BMI 39.5 \u00b1 4.86 kg/m\u00b2).", "effective_dosage": "Not specified", "study_duration": "Mean follow-up period of 14.3 \u00b1 4.44 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:08.467154+00:00"}
{"study_id": 372, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine if serum beta-alanine and kynurenine levels, along with Wnt pathway gene expression in leukocytes, could serve as biomarkers for Parkinson's disease (PD).", "results_summary": "Serum beta-alanine and kynurenine levels were higher in PD patients compared to controls, and some Wnt pathway genes showed decreased expression in leukocytes, suggesting potential biomarkers for PD detection and monitoring.", "population_specificity": "45 patients with Parkinson's disease and 45 healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:08.531572+00:00"}
{"study_id": 371, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the role of MARCKS (a protein containing alanine-rich regions) in regulating macrophage functions and inflammatory responses.", "results_summary": "The study found that MARCKS and phospho-MARCKS localized to endosomes and the Golgi apparatus upon LPS stimulation, and MARCKS knockout in macrophages reduced TNF and IL6 production, suggesting its key role in inflammation. Proteomics and metabolic assays revealed MARCKS involvement in innate immune response, cytokine production, and other molecular functions.", "population_specificity": "Macrophages (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:08.651822+00:00"}
{"study_id": 361, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop an enantiomer-specific assay for d-Ala to explore its potential as a noninvasive diagnostic biomarker for gastric cancer.", "results_summary": "The study found that d-Ala levels in saliva were significantly higher in gastric cancer cases compared to healthy individuals, suggesting its potential as a diagnostic marker. A linear detection range of 20-400 \u03bcmol/L was established with a low detection limit of 1.01 \u03bcmol/L.", "population_specificity": "Individuals with gastric cancer and healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:08.995994+00:00"}
{"study_id": 375, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of MARCKS (a protein containing Alanine-rich domains) in regulating macrophage functions and inflammatory responses.", "results_summary": "The study found that MARCKS and phospho-MARCKS localize to endosomes and the Golgi apparatus upon LPS stimulation, and CRISPR-CAS9 knockout of MARCKS downregulated TNF and IL6 production, suggesting its role in inflammatory responses.", "population_specificity": "Macrophages (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:15.168061+00:00"}
{"study_id": 373, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether L-Alanine could improve survival in mice infected with multidrug-resistant bacteria by enhancing phagocytosis and TLR4 signaling.", "results_summary": "The study found that exogenous L-Alanine promotes phagocytosis of multidrug-resistant pathogens by boosting TLR4 expression and signaling, leading to enhanced activation of the PI3K/Akt and NF-\u03baB pathways. This mechanism improved survival in mice infected with various bacteria, including V. parahaemolyticus, E. coli, P. aeruginosa, and K. pneumoniae.", "population_specificity": "Mice infected with multidrug-resistant bacteria (V. parahaemolyticus, E. coli, P. aeruginosa, K. pneumoniae).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:15.470288+00:00"}
{"study_id": 374, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of poly glycine-alanine (GA-DPR) on microglia in the context of C9-ALS, specifically its activation of the NLRP3 inflammasome and potential therapeutic interventions.", "results_summary": "The study found that GA-DPR (GA50) activates the NLRP3 inflammasome in human microglia, which can be inhibited by MCC950 or irisflorentin, suggesting a potential treatment strategy for C9-ALS.", "population_specificity": "Human HMC3 microglia model (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:15.625143+00:00"}
{"study_id": 377, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the mechanism by which foliar application of \u03b2-alanine improves salt tolerance in cotton seedlings.", "results_summary": "\u03b2-alanine at 25 mM concentration significantly improved salt tolerance, reducing mortality and enhancing plant growth, photosynthetic efficiency, and antioxidant production. Transcriptome and metabolome analyses revealed upregulated genes and accumulated metabolites linked to salinity tolerance.", "population_specificity": "Upland cotton (Gossypium hirsutum L.) seedlings", "effective_dosage": "25 mM \u03b2-alanine solution (foliar application)", "study_duration": "10 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:17.317213+00:00"}
{"study_id": 376, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to compare the effectiveness of pemafibrate and bezafibrate in normalizing alanine aminotransferase (ALT) levels in patients with nonalcoholic fatty liver disease (NAFLD).", "results_summary": "Pemafibrate showed significantly higher ALT normalization rates (60% at 12 months) compared to bezafibrate (14.3% at 12 months), with statistical significance (p=0.01). Multivariable analysis confirmed pemafibrate as a significant factor for ALT normalization (adjusted odds ratio 13.8).", "population_specificity": "Patients with NAFLD, elevated ALT levels, and dyslipidemia.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:17.416211+00:00"}
{"study_id": 378, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if low alanine aminotransferase (ALT) levels, as a marker of sarcopenia and frailty, correlate with poor prognosis in chronic lymphocytic leukemia (CLL) patients.", "results_summary": "The study found that CLL patients with low ALT levels (<12 IU/L) had significantly shorter survival, lower hemoglobin concentrations, and a higher proportion classified as Binet C score compared to those with normal ALT levels. The results suggest ALT could serve as a prognostic marker for frailty and survival in CLL patients.", "population_specificity": "716 CLL patients (161 with ALT <12 IU/L, 555 with ALT \u226512 IU/L) treated in a tertiary medical center.", "effective_dosage": "Not applicable (ALT levels measured, not administered).", "study_duration": "Retrospective study (duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:19.417003+00:00"}
{"study_id": 104339, "supplement_id": 863, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the effect of febuxostat on endothelial dysfunction and inflammation in hemodialysis patients, with serum alanine aminotransferase (ALT) tested as a safety parameter.", "results_summary": "Febuxostat significantly reduced serum uric acid, ADMA, and hsCRP levels, indicating improved endothelial function and reduced inflammation. No significant differences in serum ALT, AST, or pancytopenia were observed, suggesting no safety concerns.", "population_specificity": "Hemodialysis patients with endothelial dysfunction.", "effective_dosage": "40 mg thrice weekly.", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:27.231564+00:00"}
{"study_id": 104340, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of low-dose spironolactone and vitamin E combination versus vitamin E monotherapy on insulin resistance, hepatic steatosis, and fibrosis in NAFLD patients.", "results_summary": "The combination treatment significantly reduced NAFLD liver fat score and improved insulin resistance (HOMA-IR), while vitamin E monotherapy did not show these effects. No significant change was observed in fibrosis indices.", "population_specificity": "Patients with histologically confirmed non-alcoholic fatty liver disease (NAFLD).", "effective_dosage": "Low-dose spironolactone (specific dosage not mentioned) combined with vitamin E.", "study_duration": "52 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:27.345049+00:00"}
{"study_id": 104338, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers sought to identify the prevalence and potential impact of nonalcoholic fatty liver disease (NAFLD) in healthy volunteers for clinical trials, using alanine aminotransferase (ALT) levels as a marker.", "results_summary": "The study found that NAFLD is common and often overlooked in healthy volunteers, potentially compromising study validity and subject safety. Increased awareness and stricter ALT cutoffs were suggested to address this issue.", "population_specificity": "Healthy volunteers classified as controls between 2011 and 2015 with no known liver disease.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:27.406563+00:00"}
{"study_id": 104341, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review risk prediction tools for identifying patients at increased risk of hepatotoxicity from paracetamol poisoning, including the role of alanine transaminase (ALT) as a biomarker.", "results_summary": "The study found that normal ALT activity on presentation has a high negative predictive value for hepatotoxicity following paracetamol poisoning. The paracetamol-aminotransferase multiplication product (which includes ALT) can stratify risk, with values <1500 mg/L \u00d7 IU/L indicating low risk.", "population_specificity": "Patients with paracetamol poisoning (human studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:27.854653+00:00"}
{"study_id": 104337, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effect of hepatitis C virus eradication (SVR) on liver stiffness, particularly focusing on the role of baseline alanine aminotransferase levels and treatment type.", "results_summary": "The study found that patients achieving SVR experienced significant decreases in liver stiffness, with greater reductions in those with high baseline alanine aminotransferase levels or treated with direct-acting antiviral agents. Nearly half of patients with advanced fibrosis achieved posttreatment liver stiffness levels below 9.5 kPa.", "population_specificity": "Adults with hepatitis C virus infection who received antiviral therapy and underwent liver stiffness measurement via VCTE.", "effective_dosage": "Not specified", "study_duration": "Follow-up measurements ranged from end of therapy to 12 months or more post-therapy.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:29.045715+00:00"}
{"study_id": 104334, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers compared the effects of two surgical techniques (selective hemihepatic vascular occlusion vs. Pringle maneuver) on postoperative liver function, including alanine transaminase (ALT) levels, in patients with primary hepatocellular carcinoma.", "results_summary": "Selective hemihepatic vascular occlusion resulted in significantly lower postoperative ALT levels compared to the Pringle maneuver, indicating reduced hepatic damage and improved liver function recovery. No significant differences were found in intraoperative blood loss, transfusion, or complication rates between the two techniques.", "population_specificity": "63 patients with primary hepatocellular carcinoma undergoing hepatectomy.", "effective_dosage": "Not applicable (surgical technique comparison).", "study_duration": "Not specified (retrospective study covering June 2006 to June 2011).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:29.116971+00:00"}
{"study_id": 104336, "supplement_id": 863, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to investigate the incidence and outcome of early alanine aminotransferase (ALT) flare in treatment-naive chronic hepatitis B (CHB) patients during long-term tenofovir disoproxil fumarate (TDF) monotherapy.", "results_summary": "Early ALT flares occurred in 3% of patients within the first 8 weeks of TDF monotherapy, resolved within 4 weeks, and all patients achieved virologic response without treatment interruption. Continuous TDF monotherapy was effective and safe in these patients.", "population_specificity": "Treatment-naive chronic hepatitis B (CHB) patients (median age 48.3 years, 67.4% male, 55.8% HBeAg-positive, no cirrhosis).", "effective_dosage": "300 mg once daily.", "study_duration": "Median follow-up duration was 45 weeks (range 12-155 weeks).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:29.295748+00:00"}
{"study_id": 104335, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of various DAA regimens on liver biochemical profiles, including alanine transaminase (ALT), in chronic HCV genotype 4 patients.", "results_summary": "The study found that ALT levels declined after treatment with all DAA regimens, indicating improved liver necro-inflammatory markers in both cirrhotic and non-cirrhotic patients. Cirrhotic patients showed a rise in bilirubin and INR, with no change in albumin and a decrease in white blood cells.", "population_specificity": "272 chronic HCV genotype 4 patients (64.7% male, 39% cirrhotic) treated at Kasr Alainy Viral Hepatitis Center, Cairo University.", "effective_dosage": "Not specified for Alanine (study focused on DAA regimens: SOF/RBV, SOF/DAC \u00b1 RBV, SOF/SIM).", "study_duration": "12 or 24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:30.479905+00:00"}
{"study_id": 104348, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not investigate Alanine; it focuses on the efficacy and safety of glecaprevir and pibrentasvir for HCV treatment.", "results_summary": "The study does not report findings related to Alanine.", "population_specificity": "Patients with chronic HCV genotype 1-6 infection without cirrhosis.", "effective_dosage": "Not applicable", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:35.568997+00:00"}
{"study_id": 104343, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to assess clinical manifestations and laboratory findings of choledochal cyst in infants and older children, including alanine transaminase levels.", "results_summary": "The study found that infants with choledochal cysts were more likely to present with abdominal mass, while older children had higher rates of nausea, vomiting, and abdominal pain. Laboratory values, including alanine transaminase, were recorded but not specifically analyzed for efficacy or safety.", "population_specificity": "Infants (younger than 1 year) and older children (1-18 years) diagnosed with choledochal cyst.", "effective_dosage": "Not available", "study_duration": "Not applicable (retrospective study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:35.646597+00:00"}
{"study_id": 104344, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of nicotine on thioacetamide (TAA)-induced liver fibrosis in mice, including its impact on alanine transferase levels.", "results_summary": "Nicotine worsened TAA-induced liver injury, increased oxidative stress, and aggravated hepatic fibrosis by enhancing TGF-\u03b2 secretion and stellate cell activation. Alanine transferase levels were significantly altered in TAA-treated groups, with nicotine exacerbating the damage.", "population_specificity": "Mice with TAA-induced liver fibrosis and human liver cell lines (HepG2 and LX-2).", "effective_dosage": "Nicotine (50 or 100 \u03bcg/mL) administered daily via gastrogavage.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:35.968268+00:00"}
{"study_id": 104347, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the interobserver reproducibility of 2D-SWE in measuring liver stiffness and investigate factors related to liver 2D-SWE, including alanine transaminase.", "results_summary": "The study found good interobserver reproducibility of 2D-SWE for measuring liver stiffness, with SDM and ROIM being significantly associated with interobserver differences. Alanine transaminase was considered as a clinical factor but its specific effects were not detailed.", "population_specificity": "Rheumatoid arthritis patients treated with methotrexate.", "effective_dosage": "Not specified", "study_duration": "August 2011 to August 2012 (1 year)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:36.707881+00:00"}
{"study_id": 104349, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of telbivudine in preventing mother-to-infant HBV transmission in HBV-positive mothers during early and middle pregnancy.", "results_summary": "Telbivudine treatment significantly reduced HBV DNA levels in pregnant mothers and completely blocked mother-to-infant HBV transmission, with no infected infants in the treated groups compared to an 18.4% infection rate in the untreated group.", "population_specificity": "Pregnant women with chronic hepatitis B (n=188) and HBV DNA \u22651.0\u00d710^6 IU/mL.", "effective_dosage": "Not specified", "study_duration": "From early/middle pregnancy until delivery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:38.262329+00:00"}
{"study_id": 104346, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to investigate clinical features of treatment-naive hepatitis B patients in regions with varying endemicity levels, focusing on stages of infection and liver function markers, including alanine aminotransferase (ALT).", "results_summary": "The study found that 8.8% of patients were in the HBeAg-negative chronic hepatitis B stage with elevated ALT, with higher prevalence in males and those aged 40-60. Regional and gender differences were noted in HBV DNA levels and infection stages.", "population_specificity": "Treatment-naive hepatitis B virus (HBV) patients from high- and intermediate-endemicity regions in Southeast China (Yuhuan and Shaoxing).", "effective_dosage": "Not available", "study_duration": "Data collected during 2014-2015 (specific intervention duration not mentioned).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:39.166391+00:00"}
{"study_id": 104345, "supplement_id": 863, "safety_score": "40", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the pharmacology, pharmacokinetics, safety, and efficacy of solithromycin, a novel ketolide antibiotic, for treating community-acquired bacterial pneumonia (CABP).", "results_summary": "Solithromycin demonstrated noninferiority to moxifloxacin in treating CABP but was associated with infusion-site reactions and transient transaminitis (elevated alanine transaminase levels), raising concerns about hepatotoxicity. The FDA deemed the safety profile insufficiently characterized, requiring further large-scale studies.", "population_specificity": "Patients with moderately severe community-acquired bacterial pneumonia (CABP).", "effective_dosage": "Oral and i.v.-to-oral regimens of 5-7 days' duration (specific dosage not detailed in abstract).", "study_duration": "5-7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:40.148402+00:00"}
{"study_id": 104350, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to evaluate the feasibility and safety of pegylated-interferon \u03b1-2a (PEG-IFN\u03b1-2a) for inactive HBsAg carriers, not specifically Alanine.", "results_summary": "The study found high rates of HBsAg clearance and seroconversion with PEG-IFN\u03b1-2a-based treatments, but did not focus on Alanine's effects.", "population_specificity": "Inactive HBsAg carriers (144 subjects, divided into therapeutic and control groups).", "effective_dosage": "Not specified for Alanine.", "study_duration": "Up to 96 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:43.390220+00:00"}
{"study_id": 104351, "supplement_id": 863, "safety_score": "40", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to assess whether adding pegylated interferon to nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic hepatitis B and undetectable HBV DNA could increase HBsAg clearance.", "results_summary": "The study found that adding pegylated interferon did not significantly increase HBsAg clearance (7.8% vs. 3.2%, p=0.15) and was poorly tolerated, with higher rates of adverse events (29% grade 3, 21% grade 4) compared to nucleos(t)ide analogues alone.", "population_specificity": "Patients aged 18-75 with HBeAg-negative chronic hepatitis B, undetectable HBV DNA on stable nucleos(t)ide analogue regimens for at least 1 year, and no hepatocellular carcinoma.", "effective_dosage": "Not specified (pegylated interferon was added to existing nucleos(t)ide analogue therapy).", "study_duration": "48 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:45.327924+00:00"}
{"study_id": 104353, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to evaluate the clinical implications of anti-HBc alone serological profiles in patients, particularly regarding HBV reactivation risk and the role of alanine aminotransferase monitoring.", "results_summary": "The study found that anti-HBc alone patients may not require pre-emptive antiviral therapy but should be monitored monthly for alanine aminotransferase levels, with HBV DNA testing if levels increase. Nucleoside analogue prophylaxis is recommended for high-risk groups like liver allograft recipients and those undergoing immunosuppressive therapy.", "population_specificity": "Patients with anti-HBc alone serological profiles, including organ transplant donors, chemotherapy candidates, and individuals receiving immunosuppressive therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:45.736833+00:00"}
{"study_id": 104352, "supplement_id": 863, "safety_score": "85", "efficacy_score": 90, "quality_score": 95, "study_goal": "The researchers aimed to compare the efficacy and safety of tenofovir alafenamide (a prodrug of tenofovir) versus tenofovir disoproxil fumarate in patients with HBeAg-negative chronic HBV infection.", "results_summary": "Tenofovir alafenamide demonstrated non-inferior efficacy to tenofovir disoproxil fumarate, with 94% vs. 93% of patients achieving HBV DNA <29 IU/mL at week 48. It also showed improved bone and renal safety profiles, with smaller declines in bone mineral density and less reduction in creatinine clearance.", "population_specificity": "Adults (\u226518 years) with HBeAg-negative chronic HBV infection, elevated HBV DNA, and serum alanine aminotransferase concentrations.", "effective_dosage": "Tenofovir alafenamide 25 mg once daily; tenofovir disoproxil fumarate 300 mg once daily.", "study_duration": "48 weeks (primary endpoint), with ongoing study up to 3 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:46.043808+00:00"}
{"study_id": 104342, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of histone acetylation and HDAC activity in chronic hepatitis B (CHB) and liver failure, including the effects of HDAC inhibition on inflammation and alanine aminotransferase levels.", "results_summary": "The study found that HDAC activity and histone acetylation were altered in CHB patients, correlating with disease severity. HDAC inhibition (MS275) reduced pro-inflammatory cytokine production and increased acetylation of NF-\u03baB p65, suggesting a potential therapeutic strategy for CHB.", "population_specificity": "Patients with chronic hepatitis B (CHB) and CHB with liver failure, as well as mice with acute liver failure (ALF) and RAW264.7 murine macrophages.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:47.261902+00:00"}
{"study_id": 104354, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the efficacy and safety of total glucosides of paeony (TGP) combined with acitretin in treating moderate-to-severe plaque psoriasis, including its impact on serum alanine aminotransferase levels.", "results_summary": "The study found that TGP combined with acitretin significantly improved treatment efficacy (90% vs. 70.5% achieving a 50% reduction in Psoriasis Area and Severity Index) and reduced liver damage (6.25% vs. 20.4% serum alanine aminotransferase elevation) compared to placebo plus acitretin.", "population_specificity": "108 patients with moderate-to-severe plaque psoriasis.", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:47.363826+00:00"}
{"study_id": 104356, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate changes in serum markers related to D-alanine and L-alanine as part of a broader study on sodium benzoate's effects in early psychosis.", "results_summary": "The abstract does not report specific findings regarding Alanine's effects, as it focuses on the trial protocol rather than results.", "population_specificity": "Persons experiencing early psychosis (n=160) in Queensland, Australia.", "effective_dosage": "Not specified for Alanine (study tested 1000 mg sodium benzoate).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:47.668297+00:00"}
{"study_id": 104355, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess the activity and safety of a new regimen of nab-paclitaxel plus simplified leucovorin and fluorouracil compared to gemcitabine plus nab-paclitaxel in patients with metastatic pancreatic adenocarcinoma.", "results_summary": "The study found that nab-paclitaxel plus simplified leucovorin and fluorouracil met the primary endpoint, with 56% of patients progression-free at 4 months, and had a tolerable toxicity profile. Adverse events differed between the two treatment groups, with neutropenia, fatigue, and paraesthesia being common in the leucovorin and fluorouracil group.", "population_specificity": "Previously untreated patients with metastatic pancreatic adenocarcinoma (ECOG performance status \u22642).", "effective_dosage": "Nab-paclitaxel (125 mg/m\u00b2), simplified leucovorin and fluorouracil (details not fully specified in abstract).", "study_duration": "28-day cycles (median follow-up 13.1 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:49.876587+00:00"}
{"study_id": 104358, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine if consuming supplemental high-quality protein, potentially including Alanine, could accelerate the restoration of fat-free mass (FFM) after severe negative energy balance during military operations.", "results_summary": "The study suggests that supplemental high-quality protein may help restore FFM following negative energy balance, but specific results regarding Alanine are not detailed in the abstract. Body composition and protein turnover were measured, indicating potential benefits.", "population_specificity": "Military personnel experiencing negative energy balance during operations.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:52.919629+00:00"}
{"study_id": 104357, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to report the clinical profile of patients with Azathioprine-induced hepatotoxicity, focusing on liver injury markers such as alanine aminotransferase (ALT).", "results_summary": "The study found that 2.7% of patients developed Azathioprine-induced hepatotoxicity, with mixed hepatocellular and cholestatic patterns being most common. All patients recovered fully after drug withdrawal, though some experienced prolonged cholestasis.", "population_specificity": "Patients receiving Azathioprine from 2010 to 2015, with hepatotoxicity defined by elevated ALT, AST, or bilirubin levels.", "effective_dosage": "Not specified", "study_duration": "Follow-up until resolution of liver injury (median 41.3 days).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:53.163839+00:00"}
{"study_id": 104360, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to identify risk factors for hemorrhage after tooth extraction in patients on antiplatelet therapy, including the role of alanine transaminase levels.", "results_summary": "The study found that serum creatinine level and dual antiplatelet therapy were correlated with hemorrhage after tooth extraction, but alanine transaminase levels were not identified as a significant risk factor.", "population_specificity": "264 patients (153 men, 111 women) with a mean age of 73.6 years receiving antiplatelet therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:53.648742+00:00"}
{"study_id": 104361, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the 12-month safety and efficacy outcomes of the Elipse Balloon, a swallowable gastric balloon for weight loss, deployed without endoscopy or anesthesia.", "results_summary": "The study reported on 12-month outcomes but did not specify results related to Alanine. The abstract focuses on the Elipse Balloon's performance in weight loss, not Alanine.", "population_specificity": "12 patients aged 18-64 with a BMI of 27.0 to 40.0 kg/m\u00b2 (58.3% female, 41.7% male).", "effective_dosage": "Not mentioned", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:55.612821+00:00"}
{"study_id": 104359, "supplement_id": 863, "safety_score": "70", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the safety and efficacy of the neurokinin 3 receptor antagonist MLE4901 (which involved monitoring alanine aminotransferase levels) in reducing menopausal hot flushes.", "results_summary": "MLE4901 significantly reduced the total weekly number of hot flushes by 45 percentage points compared to placebo, with three participants experiencing a transient rise in alanine aminotransferase levels that normalized within 90 days. The treatment was well tolerated overall.", "population_specificity": "Healthy women aged 40-62 years experiencing seven or more hot flushes per 24 hours, with some severe or bothersome, and no menstruation for at least 12 months.", "effective_dosage": "40 mg orally, twice daily", "study_duration": "4 weeks per treatment period (with a 2-week washout)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:55.664802+00:00"}
{"study_id": 104363, "supplement_id": 863, "safety_score": "65", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the efficacy and safety of basal insulin peglispro with insulin glargine in insulin-na\u00efve Asian patients with type 2 diabetes.", "results_summary": "Insulin peglispro showed superior glycemic control compared to glargine, with greater reductions in glycated hemoglobin and fasting serum glucose, but was associated with increased aminotransferases and more adverse events.", "population_specificity": "Insulin-na\u00efve Asian patients with type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "26 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:55.726582+00:00"}
{"study_id": 104364, "supplement_id": 863, "safety_score": "30", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and efficacy of LY2409021, a glucagon receptor antagonist, particularly its effects on hepatic fat and other metabolic variables in patients with type 2 diabetes.", "results_summary": "LY2409021 significantly increased hepatic fat fraction and alanine aminotransferase levels compared to placebo and sitagliptin, while also showing glucose-lowering effects. However, it was associated with adverse effects like elevated blood pressure, body weight, and cholesterol, though all effects were reversible.", "population_specificity": "Patients with type 2 diabetes taking metformin and sulphonylurea.", "effective_dosage": "20 mg LY2409021.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:58.640855+00:00"}
{"study_id": 104362, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine the safety and maximum tolerated dose of mibefradil (MIB) when given sequentially with temozolomide (TMZ) in recurrent high-grade gliomas (rHGG), not specifically focusing on alanine.", "results_summary": "The study found that MIB followed by TMZ was well tolerated at the MTD (87.5 mg q.i.d.), with dose-limiting toxicities including elevated alanine aminotransferase/aspartate aminotransferase (grade 3) and sinus bradycardia. 18F-FLT PET imaging showed a significant decline in SUV signal in 2 of 10 patients after MIB treatment.", "population_specificity": "Adult patients with recurrent high-grade gliomas (20 WHO grade IV, 7 grade III; median age 50 y; median KPS 90).", "effective_dosage": "87.5 mg p.o. q.i.d. for MIB; TMZ at 150-200 mg/m2 for 5 days per 28-day cycle.", "study_duration": "7 days of MIB followed by 5 days of TMZ per 28-day cycle.", "interactions": "None mentioned for alanine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:58.837947+00:00"}
{"study_id": 104365, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The study aimed to describe the epidemiological patterns, treatment, and outcomes of Mediterranean spotted fever (MSF) in children in south Jordan, including the prevalence of elevated alanine transaminase levels.", "results_summary": "The study found that 61.8% of MSF cases had increased alanine transaminase levels, indicating liver involvement, but did not assess alanine's direct effects or safety.", "population_specificity": "Children in south Jordan with Mediterranean spotted fever (mean age: 6 years \u00b1 3.6).", "effective_dosage": "Not specified for alanine.", "study_duration": "Not specified for alanine.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:01.180259+00:00"}
{"study_id": 104366, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the correct use of reference intervals and decision limits for clinical laboratory reports, including alanine aminotransferase (ALT), among other measurands.", "results_summary": "The study emphasized the importance of gender- and age-related reference intervals for clinical measurands like ALT but did not report specific findings on alanine's effects. It highlighted risks associated with lacking such intervals.", "population_specificity": "General clinical populations, including pediatric and elderly groups.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:01.588351+00:00"}
{"study_id": 104367, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers were comparing the benefit-risk profile of ipilimumab 10 mg/kg versus 3 mg/kg in patients with advanced melanoma, not specifically studying alanine.", "results_summary": "The study found increased alanine aminotransferase levels as a treatment-related adverse event in some patients, but the focus was on ipilimumab's effects, not alanine's.", "population_specificity": "Patients with untreated or previously treated unresectable stage III or IV melanoma.", "effective_dosage": "Not applicable (study focused on ipilimumab, not alanine).", "study_duration": "Four doses administered every 3 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:02.193415+00:00"}
{"study_id": 104369, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to analyze prognostic factors affecting mortality in hospitalized tetanus patients, including high alanine aminotransferase (ALT) levels.", "results_summary": "High ALT values on admission were statistically associated with increased mortality in tetanus patients (p < 0.05). The study did not evaluate Alanine as a supplement but noted its association with poor outcomes in this context.", "population_specificity": "Adult patients over 15 years with tetanus from 25 medical centers.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:03.970651+00:00"}
{"study_id": 104370, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "The researchers aimed to evaluate the HBeAg seroconversion rate and its predictors, including alanine aminotransferase (ALT) levels, in chronic hepatitis B patients treated with nucleos(t)ide analogues.", "results_summary": "Elevated ALT levels were identified as a predictor of HBeAg seroconversion (p<0.001, HR=2.049). The study found cumulative HBeAg seroconversion rates increased over time, reaching 50.5% after 8 years.", "population_specificity": "251 chronic hepatitis B patients from four hospitals in Hebei province, China.", "effective_dosage": "Not specified for alanine (ALT levels were measured, not administered).", "study_duration": "Up to 8 years (retrospective study from 2001-2009).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:04.734572+00:00"}
{"study_id": 104368, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine the efficacy of abiraterone acetate with prednisone in high-risk prostate cancer patients with a suboptimal response to hormonal induction, not specifically Alanine.", "results_summary": "The study found that 13% of patients achieved a PSA level of 0.2 ng/mL or lower, and 33% achieved a partial response. The therapy was generally well tolerated, with one incident of grade 4 alanine aminotransferase elevation.", "population_specificity": "Men with metastatic prostate cancer and a PSA level higher than 4.0 ng/mL after 6-12 months of ADT.", "effective_dosage": "Abiraterone acetate, 1000 mg once daily, with prednisone, 5 mg twice daily.", "study_duration": "Not explicitly stated in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:05.405417+00:00"}
{"study_id": 104371, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers sought to review the pathophysiology, clinical presentation, and outcomes of ischemic hepatitis, including its association with cardiovascular disease and potential therapies.", "results_summary": "The study found that ischemic hepatitis is linked to cardiovascular disease and systemic hypoperfusion, leading to transient elevation in alanine aminotransferase (ALT). Mortality is high and treatment focuses on addressing the underlying hemodynamic disturbance.", "population_specificity": "Critically ill patients with underlying cardiac, circulatory, or respiratory failure.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:05.790952+00:00"}
{"study_id": 104372, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 25, "quality_score": 65, "study_goal": "The study aimed to evaluate the safety, efficacy, and toxicity of hepatic intra-arterial infusion therapy (FMP therapy) in patients with advanced hepatocellular carcinoma (HCC), not specifically Alanine.", "results_summary": "The study found elevated serum alanine aminotransferase (14%) as a non-hematological toxicity, but the focus was on FMP therapy's overall tumor response and survival, which were not favorable.", "population_specificity": "Patients with advanced hepatocellular carcinoma (HCC).", "effective_dosage": "Not applicable (study focused on FMP therapy, not Alanine).", "study_duration": "Continuous intra-arterial infusion of 5-fluorouracil from Day 1 through Day 5, with mitoxantrone and cisplatin administered on Day 1.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:09.027344+00:00"}
{"study_id": 104373, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of switching from entecavir (ETV) to telbivudine (LdT) in maintaining undetectable HBV DNA levels in patients with chronic hepatitis B.", "results_summary": "The study found that 83.3% of patients who switched to LdT maintained treatment success, while 16.7% experienced virological rebound with drug-resistant mutations. ETV followed by LdT was ineffective for long-term HBV treatment.", "population_specificity": "Patients with undetectable HBV DNA and normal alanine aminotransferase levels after initial ETV treatment.", "effective_dosage": "Not specified", "study_duration": "96 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:10.741233+00:00"}
{"study_id": 104374, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The study aimed to compare the effects of gliclazide, liraglutide, and metformin on HbA1c levels, intrahepatic fat content, and liver function in T2DM patients with NAFLD.", "results_summary": "Reductions in HbA1c and intrahepatic fat content were observed in all groups, with liraglutide and metformin showing greater improvements than gliclazide. Liraglutide and metformin also reduced weight and improved liver function, with correlations between fat reduction and improvements in alanine aminotransferase, triglycerides, and weight.", "population_specificity": "Type 2 diabetes mellitus (T2DM) patients with non-alcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:11.611074+00:00"}
{"study_id": 104375, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of off-treatment viral kinetics, including alanine aminotransferase (ALT) levels, in predicting relapse after discontinuation of nucleos(t)ide analogue therapy in chronic hepatitis B patients.", "results_summary": "The study found that lower relapse rates were associated with younger age and low end-of-treatment HBsAg levels. Elevated and persistent HBV DNA levels were predictive of biochemical relapse, as indicated by ALT levels >2 times the upper limit of normal.", "population_specificity": "Noncirrhotic Asian patients with chronic hepatitis B (82 participants, 60 HBeAg-positive and 22 HBeAg-negative).", "effective_dosage": "Not specified", "study_duration": "Not specified (follow-up period mentioned but not intervention duration)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:11.894512+00:00"}
{"study_id": 104376, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to evaluate the antitumor effects of idelalisib (a PI3K\u03b4 inhibitor) in relapsed/refractory Hodgkin lymphoma, not specifically Alanine.", "results_summary": "The study found that idelalisib had modest single-agent activity (20% overall response rate) in heavily pretreated Hodgkin lymphoma patients, with common adverse events including alanine aminotransferase elevation (8%).", "population_specificity": "25 patients with relapsed/refractory Hodgkin lymphoma (median age 42, heavily pretreated).", "effective_dosage": "150 mg twice daily (increased to 300 mg twice daily upon progression).", "study_duration": "Not explicitly stated (follow-up included median progression-free survival of 2.3 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:12.976426+00:00"}
{"study_id": 104378, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to assess the frequency, severity, and resolution of ALT flares in pregnant women with chronic hepatitis B (CHB) who were treated with antiviral therapy before or during pregnancy.", "results_summary": "ALT flares were common during pregnancy and postpartum, particularly in women who discontinued antiviral therapy before pregnancy, during the first trimester, or at delivery. No flares were observed in women who continued treatment.", "population_specificity": "Pregnant women with chronic hepatitis B (CHB) who had current or prior antiviral treatment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:13.078819+00:00"}
{"study_id": 104377, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to characterize the population pharmacokinetics of selumetinib and its active metabolite N-desmethyl-selumetinib in cancer patients, including the influence of covariates like alanine aminotransferase.", "results_summary": "The study found that selumetinib and N-desmethyl-selumetinib pharmacokinetics were best described by specific compartment models, with significant covariates for clearance including alanine aminotransferase. Flat dosing was deemed appropriate for adults, while body-surface area-based dosing was recommended for pediatric patients.", "population_specificity": "Adult and pediatric patients with cancer.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:13.295202+00:00"}
{"study_id": 104379, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effectiveness of exercise interventions on liver enzymes, including alanine aminotransferase, in overweight and obese youth.", "results_summary": "Exercise did not significantly alter alanine aminotransferase levels, though it reduced visceral and subcutaneous fat, intrahepatic fat, and gamma-glutamyl transferase.", "population_specificity": "Overweight and obese youth (1231 participants across 14 clinical trials).", "effective_dosage": "Not specified (exercise interventions varied by study).", "study_duration": "Not specified (duration varied by study).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:13.788095+00:00"}
{"study_id": 104380, "supplement_id": 863, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the real-life safety and efficacy of teriflunomide, including its effects on alanine aminotransferase (ALT) levels, in patients with relapsing-remitting multiple sclerosis.", "results_summary": "ALT levels remained normal in 95.3% of blood samples, with only 4.7% showing abnormalities, mostly mild. One-third of patients had at least one abnormal ALT value, but severe abnormalities were rare.", "population_specificity": "102 patients with relapsing-remitting multiple sclerosis, predominantly female, transitioning from interferon-beta treatment.", "effective_dosage": "Teriflunomide 14 mg once daily (specific dosage for alanine not provided).", "study_duration": "Up to 28 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:17.717538+00:00"}
{"study_id": 104382, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficacy and usefulness of switching from alogliptin or pioglitazone monotherapy to a fixed-dose combination therapy (Alo-Pio FDCT) in patients with type 2 diabetes mellitus.", "results_summary": "The study found significant improvements in hemoglobinA1c (HbA1c) levels after switching to Alo-Pio FDCT, indicating enhanced glycemic control compared to monotherapy.", "population_specificity": "Outpatients with type 2 diabetes mellitus (50 treated with alogliptin and 47 treated with pioglitazone).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:19.967796+00:00"}
{"study_id": 104383, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of different \u03b3-isoforms on AMPK activation by the small molecule 991, focusing on the role of the \u03b32-isoform.", "results_summary": "The study found that 991 led to greater activation of \u03b32-containing AMPK complexes compared to \u03b31 or \u03b33, with this effect dependent on the \u03b32-isoform's N-terminal region. The role of Ser was ruled out as a contributing factor.", "population_specificity": "Not specified (likely in vitro or cellular models, as human subjects are not mentioned).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:20.642825+00:00"}
{"study_id": 104381, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were attempting to determine the maximum tolerated dose of lenalidomide in combination with rituximab and idelalisib in relapsed follicular and mantle cell lymphoma, not specifically evaluating Alanine.", "results_summary": "The study found that the combination of idelalisib, lenalidomide, and rituximab was excessively toxic, with dose-limiting toxicities including grade 4 AST/ALT elevation, sepsis syndrome, and severe rashes, leading to trial closure. Alanine aminotransferase (ALT) elevation was noted as an adverse event but was not the focus of the study.", "population_specificity": "Patients with relapsed mantle cell lymphoma or follicular lymphoma who had not received previous lenalidomide or idelalisib.", "effective_dosage": "Not specified for Alanine.", "study_duration": "Not specified for Alanine.", "interactions": "None mentioned for Alanine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:21.633081+00:00"}
{"study_id": 104387, "supplement_id": 863, "safety_score": "30", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and outcomes of drug rechallenge in cases of drug-induced liver injury (DILI) involving alanine aminotransferase (ALT) elevations.", "results_summary": "The study found that drug rechallenge following DILI is associated with significant risks, including up to 13% mortality, and identified multiple risk factors for positive rechallenge, such as high daily doses and mitochondrial impairment. Standardized monitoring systems in oncology trials have improved rechallenge safety, but caution remains necessary for high-risk drugs.", "population_specificity": "Patients with drug-induced liver injury (DILI) involving ALT elevations.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:21.868038+00:00"}
{"study_id": 104385, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether red LED PWM radiation treatment during laparoscopic cholecystectomy reduces adverse effects, as measured by ALT, AST, and ESR levels.", "results_summary": "The test group showed significant reductions in postsurgery increases of ALT, AST, and ESR levels compared to the control group, indicating reduced adverse effects. The treatment slightly increased surgery time but did not affect surgical best practices.", "population_specificity": "263 patients undergoing laparoscopic cholecystectomy.", "effective_dosage": "Red LED light (\u03bb = 625 \u00b1 5 nm, 76 Hz, duty cycle 23%, 15-30 mW/cm\u00b2) applied for 2 minutes.", "study_duration": "Single 2-minute application during surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:21.935969+00:00"}
{"study_id": 104386, "supplement_id": 863, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and efficacy of deferasirox, an iron chelator, in young pediatric patients with transfusional hemosiderosis, focusing on renal and hepatic function.", "results_summary": "The study found that deferasirox was generally safe, with low rates of renal and hepatic abnormalities, and effective in reducing serum ferritin levels over 5 years. No new safety signals were identified.", "population_specificity": "Pediatric patients aged 2 to less than 6 years with transfusional hemosiderosis, predominantly \u03b2-thalassemia.", "effective_dosage": "Mean dose of 25.8 \u00b1 6.5 mg/kg per day.", "study_duration": "Median of 59.9 months (approximately 5 years).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:22.045662+00:00"}
{"study_id": 104384, "supplement_id": 863, "safety_score": "75", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers investigated the adherence and safety of dolutegravir (DTG) with tenofovir disoproxil fumarate-emtricitabine (TDF-FTC) as HIV postexposure prophylaxis (PEP), including the impact on alanine aminotransferase levels.", "results_summary": "The study found that raised alanine aminotransferase (22%) was the most common laboratory adverse event, but no clinical hepatitis occurred. PEP completion was high (90%), with no HIV infections reported through week 12.", "population_specificity": "HIV-uninfected gay and bisexual men requiring PEP.", "effective_dosage": "DTG (50 mg daily) with TDF-FTC (300/200 mg daily).", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:22.338341+00:00"}
{"study_id": 104388, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness and tolerance of an all-oral regimen (sofosbuvir plus daclatasvir) in patients with HCV-associated cryoglobulinemia vasculitis, including monitoring alanine aminotransferase levels.", "results_summary": "The study found that 90.2% of patients achieved a complete clinical response, with significant reductions in cryoglobulin levels and no serious adverse events or relapses during follow-up. Alanine aminotransferase levels were monitored but specific outcomes related to alanine were not highlighted.", "population_specificity": "Patients with active HCV-associated cryoglobulinemia vasculitis (median age 56 years, 53.6% women).", "effective_dosage": "Sofosbuvir (400 mg/day) plus daclatasvir (60 mg/day).", "study_duration": "12 weeks (n=32) or 24 weeks (n=9).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:27.708934+00:00"}
{"study_id": 104390, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers were examining whether cold IV saline combined with ice-sheeting affects alanine aminotransferase levels in heat casualties.", "results_summary": "The study found no significant difference in alanine aminotransferase levels between the two treatment groups (ice-sheeting with ambient IV saline vs. ice-sheeting with cold IV saline).", "population_specificity": "U.S. Army heat casualties admitted to Martin Army Community Hospital.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:27.765402+00:00"}
{"study_id": 104389, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic efficacy of lamivudine (LAM) combined with ACEI/ARB versus ACEI/ARB monotherapy in HBV-GN patients with mild to moderate proteinuria.", "results_summary": "LAM plus ACEI/ARB therapy was more effective in reducing 24-h urinary protein excretion and improving liver function markers (alanine aminotransferase and aspartate aminotransferase) compared to ACEI/ARB monotherapy, while maintaining kidney function. A higher proportion of patients achieved remission in the combination therapy group.", "population_specificity": "HBV-GN patients with mild to moderate proteinuria.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:28.505413+00:00"}
{"study_id": 104393, "supplement_id": 863, "safety_score": "30", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to assess the benefits and harms of external beam radiotherapy, including its effects on alanine aminotransferase levels, in managing localized unresectable hepatocellular carcinoma.", "results_summary": "The study found that combined external beam radiotherapy and chemoembolisation was associated with increased toxicity, including elevated alanine aminotransferase levels, but also lower mortality and improved response rates compared to chemoembolisation alone.", "population_specificity": "Adults (median age ~52 years) with unresectable hepatocellular carcinoma, predominantly male, from China.", "effective_dosage": "Not specified", "study_duration": "Median follow-up ranged from one to three years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:29.689225+00:00"}
{"study_id": 104395, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to assess the prevalence of elevated liver enzymes, including alanine aminotransferase (ALT), in adults with type 1 diabetes mellitus (T1DM) and its association with cardiovascular risk factors.", "results_summary": "Elevated liver enzymes, including ALT, were found in 20% of patients and were associated with worse glycaemic control, higher BMI, and increased cardiovascular risk factors such as dyslipidemia and hypertension. A subgroup with persistently elevated ALT showed stronger associations with these adverse outcomes.", "population_specificity": "Adults with type 1 diabetes mellitus (T1DM) from Germany and Austria.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:30.354658+00:00"}
{"study_id": 104392, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the relationship between alanine aminotransferase (ALT) levels and HBeAg seroconversion in chronic hepatitis B (CHB) patients undergoing tenofovir disoproxil fumarate (TDF) treatment.", "results_summary": "The study found that ALT levels declined to normal by week 24 in seroconverted patients and remained stable, with a predictive cutoff value of 41.5 U/L for HBeAg seroconversion. Additionally, ALT decline was correlated with HBV DNA and Treg levels in seroconverted patients.", "population_specificity": "32 HBeAg-positive chronic hepatitis B (CHB) patients", "effective_dosage": "Not specified", "study_duration": "96 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:30.361494+00:00"}
{"study_id": 104391, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the impacts of ADMA and SDMA on human health and disease, focusing on their synthesis, metabolism, pathophysiological roles, and potential therapies.", "results_summary": "The study found that ADMA and SDMA are toxic uremic toxins that inhibit nitric oxide production and are strong predictors of cardiovascular events and death. No specific pharmacological therapy currently exists to lower their levels or counteract their effects.", "population_specificity": "Not specified (general human health and disease context)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:30.716877+00:00"}
{"study_id": 104396, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and safety of pegylated interferon + ribavirin (PR) with or without telaprevir (TVR) in treating acute hepatitis C genotype 1 infection in HIV-coinfected men who have sex with men (MSM).", "results_summary": "The study found moderate response rates and additional toxicities with TVR + PR, suggesting 1st generation HCV protease inhibitors should not be used for acute HCV. Dual DAA therapy was supported by recent data, but optimal treatment duration remains unclear.", "population_specificity": "HIV-coinfected men who have sex with men (MSM) with acute hepatitis C genotype 1 infection.", "effective_dosage": "Not specified", "study_duration": "12-24 weeks for TVR + PR arm, 24-48 weeks for PR alone arm.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:31.157402+00:00"}
{"study_id": 104399, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate whether alanine aminotransferase (ALT) could serve as a first-trimester biomarker for predicting gestational diabetes mellitus (GDM).", "results_summary": "The abstract mentions alanine aminotransferase as one of several potential biomarkers for GDM, but no specific findings about its predictive efficacy or clinical utility are detailed.", "population_specificity": "Pregnant women in their first trimester.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:37.165786+00:00"}
{"study_id": 104398, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of a specific probiotic compound on biochemical markers, including alanine aminotransferase (ALT), in obese children with nonalcoholic fatty liver disease (NAFLD).", "results_summary": "The probiotic intervention significantly reduced ALT levels (from 32.8 to 23.1 U/L) and improved liver sonography findings in 53.1% of patients, along with reductions in cholesterol, LDL-C, triglycerides, and waist circumference.", "population_specificity": "Obese children with sonographic NAFLD (n=64).", "effective_dosage": "Probiotic capsule containing Lactobacillus acidophilus (3\u00d710 CFU), Bifidobacterium lactis (6\u00d710 CFU), Bifidobacterium bifidum (2\u00d710 CFU), and Lactobacillus rhamnosus (2\u00d710 CFU) daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:37.612491+00:00"}
{"study_id": 104397, "supplement_id": 863, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the pharmacokinetics, pharmacodynamics, safety, and tolerability of PF-06291874 (a glucagon receptor antagonist) as monotherapy in subjects with type 2 diabetes mellitus (T2DM).", "results_summary": "PF-06291874 demonstrated dose-dependent reductions in mean daily glucose (40.3 to 68.8 mg/dL) and fasting plasma glucose (27.1 to 57.2 mg/dL) after 28 days. Small, dose-dependent increases in alanine aminotransferase and aspartate aminotransferase were observed, but the incidence of values >3\u00d7 upper limit of normal was similar across doses.", "population_specificity": "Subjects with type 2 diabetes mellitus (T2DM) after a \u22654-week antidiabetic therapy washout period.", "effective_dosage": "15, 35, 75, or 150 mg once daily.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:37.685538+00:00"}
{"study_id": 104403, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of ECHS1 mutations on amino acid catabolism, particularly valine, and assess secondary pyruvate dehydrogenase complex (PDC) deficiency in SCEH deficiency cases.", "results_summary": "The study found elevated plasma alanine levels in a patient with SCEH deficiency, alongside other metabolic abnormalities. Secondary PDC deficiency was observed in about half of the reviewed cases with primary SCEH deficiency.", "population_specificity": "A neonatal patient with severe metabolic disorder and 16 other cases with ECHS1 mutations.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:38.816029+00:00"}
{"study_id": 104400, "supplement_id": 863, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and effectiveness of allogeneic mesenchymal stem cell transplantation (MSCT) in patients with liver cirrhosis caused by autoimmune diseases, including changes in alanine transaminase levels.", "results_summary": "The study found that alanine transaminase values decreased at 6 months, 1 year, and 2 years post-transplantation, though without statistical significance. Serum albumin levels improved significantly at 2 years, and MELD scores improved over follow-up periods.", "population_specificity": "Patients with liver cirrhosis caused by autoimmune diseases (n=26).", "effective_dosage": "Not specified (various MSC sources: umbilical cord, cord blood, bone marrow).", "study_duration": "Follow-up periods of 6 months, 1 year, and 2 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:39.130460+00:00"}
{"study_id": 104402, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the potential of alanine racemase inhibitors as novel antimicrobial agents targeting Gram-positive bacteria like Enterococcus faecium and E. faecalis.", "results_summary": "The abstract highlights alanine racemase inhibitors as a promising novel compound class for targeting Gram-positive bacteria, with potential for future antimicrobial drug development and clinical use. However, specific efficacy data for alanine racemase inhibitors are not detailed in the abstract.", "population_specificity": "Gram-positive bacteria (e.g., Enterococcus faecium and E. faecalis) in preclinical or animal models (implied by the mention of efficacy in animal models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:39.368058+00:00"}
{"study_id": 104401, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify factors associated with persistent increases in alanine aminotransferase (ALT) levels in patients with chronic hepatitis B (CHB) receiving long-term tenofovir disoproxil fumarate therapy.", "results_summary": "The study found that HBeAg seropositivity, hepatic steatosis (\u22655% at baseline or year 5), and age \u226540 were significantly associated with persistent ALT elevation. Patients with steatosis at baseline had a 50% likelihood of elevated ALT after 5 years of treatment.", "population_specificity": "471 HBeAg-positive and HBeAg-negative patients with chronic hepatitis B.", "effective_dosage": "Not specified (tenofovir disoproxil fumarate therapy details not provided).", "study_duration": "5 years (240 weeks).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:39.978296+00:00"}
{"study_id": 104404, "supplement_id": 863, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of a 24-week daclatasvir and asunaprevir therapy for patients with chronic hepatitis C virus (HCV)-1b infection, including those excluded from clinical trials.", "results_summary": "The study found similar sustained virological response (SVR12) rates (87.0% vs. 86.7%) and safety profiles between patients who met and did not meet clinical trial inclusion criteria. Alanine aminotransferase (ALT) elevation led to a low discontinuation rate (2.9%), and adverse events were manageable.", "population_specificity": "Patients with chronic HCV-1b infection, including those excluded from clinical trials (n=651).", "effective_dosage": "Not specified (dual oral therapy with daclatasvir and asunaprevir).", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:41.580623+00:00"}
{"study_id": 104406, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether sociodemographic and HBV-specific clinical factors, including alanine aminotransferase levels, were associated with health-related quality of life in pediatric patients with chronic HBV.", "results_summary": "Increased alanine aminotransferase levels were negatively associated with psychosocial quality of life in young children (5-<10 years), but no other significant associations were found for alanine aminotransferase in other subscales or age groups.", "population_specificity": "Pediatric patients (5-<18 years) chronically infected with HBV and treatment-na\u00efve.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:47.828273+00:00"}
{"study_id": 104405, "supplement_id": 863, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers compared the safety and efficacy of atorvastatin combined with ezetimibe versus double-dose atorvastatin in elderly patients with acute coronary syndrome, with a focus on liver dysfunction (alanine aminotransferase levels).", "results_summary": "The study found that the combined therapy group had a lower incidence of elevated alanine aminotransferase levels (2.8% vs. 9.0%) compared to the double-dose atorvastatin group, suggesting better liver safety. However, the efficacy in reducing major adverse cardiovascular events was similar between the two groups.", "population_specificity": "Octogenarian patients with acute coronary syndrome.", "effective_dosage": "Atorvastatin 10 mg/d + ezetimibe 10 mg/d (combined group) vs. atorvastatin 20 mg/d (double-dose group).", "study_duration": "One year.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:49.572781+00:00"}
{"study_id": 104408, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore associations between alcohol-induced liver injury, endotoxemia, and inflammation, including sex-related differences, using alanine aminotransferase (ALT) as a marker.", "results_summary": "Elevated ALT and other liver damage markers indicated mild alcoholic liver disease (ALD), with greater necrotic hepatocyte cell death in affected individuals. Females showed higher liver injury markers despite lower alcohol consumption, and liver injury was linked to systemic inflammation and endotoxemia, which improved with abstinence.", "population_specificity": "48 alcohol-dependent individuals (34 males, 14 females) admitted to an alcohol detoxification program, stratified by baseline ALT levels.", "effective_dosage": "Not specified", "study_duration": "15 days (baseline, day 8, day 15)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:49.605096+00:00"}
{"study_id": 104411, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to investigate whether polymorphisms in certain genes could serve as predictive markers for adverse drug reactions to regorafenib in cancer patients.", "results_summary": "The study found no association between the investigated polymorphisms and adverse reactions to regorafenib, concluding that the absence of such markers limits predictive capability.", "population_specificity": "37 Japanese cancer patients treated with regorafenib.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:49.996639+00:00"}
{"study_id": 104409, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 96, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the tolerability and efficacy of sofosbuvir and ribavirin in patients with HCV genotype 2 infection, including factors associated with ALT non-normalization after treatment.", "results_summary": "The study found a high SVR12 rate (96.1%) in patients treated with sofosbuvir and ribavirin. Elevated M2BpGi levels were associated with ALT non-normalization post-treatment, suggesting a need for careful monitoring in these patients.", "population_specificity": "208 patients with chronic HCV genotype 2 infection, including cirrhotic patients.", "effective_dosage": "Sofosbuvir 400 mg and weight-based ribavirin dosing.", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:51.342817+00:00"}
{"study_id": 104412, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the performance of acoustic radiation force impulse (ARFI) elastography with liver biopsy for quantifying liver fibrosis levels in patients with chronic hepatitis B (CHB), using alanine aminotransferase levels as part of the diagnostic criteria.", "results_summary": "The study found a strong positive correlation between ARFI velocity values and liver fibrosis scores (Ishak system), with ARFI demonstrating high sensitivity (83%) and specificity (98%) at a cutoff value of 1.75 m/s for differentiating fibrosis stages.", "population_specificity": "100 CHB patients and 30 healthy controls (total 130 individuals, predominantly male).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:51.637211+00:00"}
{"study_id": 104410, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the differences in fatty acid content between healthy subjects and NAFLD patients and quantify the benefits of n-3 PUFA therapy, including its effects on alanine aminotransferase (ALT) levels.", "results_summary": "The study found that n-3 PUFA supplementation significantly reduced ALT and AST levels, marginally reduced liver fat content, and significantly lowered triglyceride levels, but did not affect fasting glucose. A dose-response analysis indicated that higher EPA+DHA intake was associated with greater reductions in ALT, AST, liver fat, and triglycerides.", "population_specificity": "Non-alcoholic fatty liver disease (NAFLD) patients and healthy controls.", "effective_dosage": "1 g per day increment of EPA+DHA was associated with reductions in ALT, AST, liver fat, and triglycerides.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:52.111032+00:00"}
{"study_id": 104413, "supplement_id": 863, "safety_score": "75", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of SOR-C13 (containing Alanine) in patients with advanced epithelial tumors.", "results_summary": "SOR-C13 was generally safe, with transient Grade 2 hypocalcemia as the most common drug-related adverse event. Stable disease was observed in 54.5% of evaluable patients, with one pancreatic tumor showing a 27% reduction.", "population_specificity": "Patients with advanced tumors of epithelial origin.", "effective_dosage": "1.375, 2.75, 4.13, 5.5, and 6.2 mg/kg (IV, QD on days 1-3 and 8-10 of a 21-day cycle).", "study_duration": "Administered over two 21-day cycles (6 total doses per cycle).", "interactions": "Calcium and vitamin D supplementation mitigated hypocalcemia.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:54.674357+00:00"}
{"study_id": 104414, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were investigating the infectivity and disease severity of transfusion-transmitted hepatitis E virus (HEV) in relation to immunosuppression, not Alanine.", "results_summary": "The study found that the infectivity of HEV-contaminated blood components was 50%, and immunosuppression may lead to chronic sequelae from transfusion-transmitted HEV.", "population_specificity": "Transfusion recipients, particularly those who are immunosuppressed.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:56.158492+00:00"}
{"study_id": 104416, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of reducing full-array liver function tests (LFTs) in favor of a single alanine transaminase (ALT) test for statin monitoring.", "results_summary": "The intervention significantly reduced full LFT testing by 24.3% in statin users, demonstrating that a single ALT test combined with prudent testing guidance is effective. No adverse effects were reported, suggesting the approach is both cost-effective and beneficial for patients.", "population_specificity": "650,000 patients across two east London clinical commissioning groups, with 17.6% on statins.", "effective_dosage": "Not specified", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:58.471499+00:00"}
{"study_id": 104415, "supplement_id": 863, "safety_score": "75", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the safety and patient satisfaction of deferasirox dispersible tablets (DT) and film-coated tablets (FCT) formulations in patients with transfusion-dependent thalassemia or myelodysplastic syndromes.", "results_summary": "The study found that both formulations had similar overall adverse event rates, but FCT showed fewer severe events and better patient-reported outcomes, including adherence, satisfaction, and palatability. Laboratory parameters remained stable, and treatment compliance was higher with FCT.", "population_specificity": "Chelation-na\u00efve or pre-treated patients aged \u226510 years with transfusion-dependent thalassemia or IPSS-R very-low-, low-, or intermediate-risk myelodysplastic syndromes.", "effective_dosage": "Not specified", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:58.487399+00:00"}
{"study_id": 104417, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine whether converting long-term liver graft recipients from sirolimus to everolimus is safe and effective.", "results_summary": "The study found no significant complications or rejection episodes after conversion, though some biochemical changes (e.g., higher alanine aminotransferase levels) were observed. Everolimus appeared to be a viable alternative to sirolimus in this population.", "population_specificity": "Long-term liver graft recipients (16 patients, 8 female/8 male, median age 66 years).", "effective_dosage": "Not specified (majority required no dose adjustment).", "study_duration": "Median follow-up after conversion not specified (patients were converted at a median of 10.1 years post-transplant).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:58.830718+00:00"}
{"study_id": 104419, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the predictive value of serum alanine transaminase (ALT) and aspartate transaminase (AST) levels for short- and long-term mortality in STEMI patients treated with primary PCI.", "results_summary": "Elevated ALT and AST levels (\u226595th percentile) were significantly associated with increased short- and long-term all-cause mortality in STEMI patients, with worse outcomes when both enzymes were elevated. The associations remained significant after adjustments for age and gender but not after full covariate adjustment.", "population_specificity": "2417 consecutive STEMI patients with no preexisting liver disease treated with primary PCI.", "effective_dosage": "Not specified", "study_duration": "Outcomes measured at 1 month and 2 years post-procedure.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:00.283164+00:00"}
{"study_id": 104418, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare the rates of HBsAg loss and HCC development in HBeAg-negative patients with cirrhosis who discontinued versus continued nucleoside analogue (NA) treatment.", "results_summary": "The study found that patients who discontinued NA treatment had a higher rate of HBsAg loss (46.7% over 6 years) compared to those who continued treatment, with no significant difference in HCC development between the groups. Two patients experienced post-treatment alanine aminotransferase flare with hepatic decompensation but recovered after retreatment.", "population_specificity": "HBeAg-negative patients with compensated cirrhosis.", "effective_dosage": "Not specified for alanine; entecavir treatment was continued for at least 4 years in the continuing group.", "study_duration": "At least 12 months for the discontinuing group and at least 4 years for the continuing group.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:02.093786+00:00"}
{"study_id": 104422, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were reviewing diagnostic features of non-mechanical causes of cholestasis, not specifically studying Alanine.", "results_summary": "The abstract does not report any findings specific to Alanine's effects; it focuses on cholestatic liver disease characteristics and diagnostic approaches.", "population_specificity": "Patients with cholestatic liver disease (not specific to Alanine).", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:02.758116+00:00"}
{"study_id": 104420, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers were evaluating the efficacy and safety of glecaprevir (GLE) + pibrentasvir (PIB) \u00b1 ribavirin (RBV) in HCV genotype 1-infected patients with prior virologic failure to HCV DAA-containing therapy, not specifically studying Alanine.", "results_summary": "The study found that the combination of GLE and PIB was highly efficacious and well tolerated in patients with HCV genotype 1 infection and prior failure of DAA-containing therapy; RBV coadministration did not improve efficacy. No relevant laboratory abnormalities in alanine aminotransferase were observed.", "population_specificity": "HCV genotype 1-infected patients with prior virologic failure to HCV DAA-containing therapy, without cirrhosis.", "effective_dosage": "200 mg GLE + 80 mg PIB (arm A), 300 mg GLE + 120 mg PIB with 800 mg once-daily RBV (arm B), or 300 mg GLE + 120 mg PIB without RBV (arm C).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:03.121586+00:00"}
{"study_id": 104421, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to compare the efficacy and safety of ceritinib versus platinum-based chemotherapy in untreated patients with ALK-rearranged non-small-cell lung cancer (NSCLC), not specifically to evaluate alanine.", "results_summary": "The study found that ceritinib significantly improved progression-free survival compared to chemotherapy, with common adverse events including increased alanine aminotransferase levels in the ceritinib group.", "population_specificity": "Patients with stage IIIB/IV ALK-rearranged non-squamous NSCLC.", "effective_dosage": "Not specified for alanine (ceritinib dosage: 750 mg/day).", "study_duration": "Not specified for alanine (study period: Aug 19, 2013, to May 11, 2015).", "interactions": "None mentioned for alanine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:03.543822+00:00"}
{"study_id": 104424, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the metabolic effects of metformin, including its impact on alanine levels, and identify biomarkers predicting post-MI left ventricular function and infarct size.", "results_summary": "The study found that metformin increased alanine levels and reduced phospholipid content in very large HDL particles. HDL triglyceride concentrations were predictive of post-MI left ventricular ejection fraction and infarct size.", "population_specificity": "Patients with ST-segment-elevated myocardial infarction (STEMI).", "effective_dosage": "Not specified for alanine (metformin dosage not detailed in abstract).", "study_duration": "4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:06.413234+00:00"}
{"study_id": 104425, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the therapeutic effect of reimplantation of biliary metal stents in patients with recurrent malignant obstructive jaundice and explore the prognostic value of inflammation-based markers, including alanine aminotransferase (ALT).", "results_summary": "Levels of ALT, AST, and bilirubin significantly reduced after reimplantation. Elevated systemic immune-inflammation index (SII) and platelets-to-lymphocyte ratio (PLR) were identified as predictors of poor overall survival.", "population_specificity": "Patients with recurrent malignant obstructive jaundice after biliary metal stent implantation (n=33).", "effective_dosage": "Not specified", "study_duration": "Follow-up median of 10 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:07.820023+00:00"}
{"study_id": 104423, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether switching from entecavir to telbivudine could further decrease HBsAg levels in patients with undetectable HBV DNA after initial entecavir treatment.", "results_summary": "Sequential therapy with entecavir followed by telbivudine resulted in a high rate of virologic breakthrough and drug resistance without any beneficial effect on HBsAg decline. The study concluded that low genetic barrier drugs like telbivudine should not be used as a switch treatment strategy after achieving virologic response with high genetic barrier drugs.", "population_specificity": "Patients with HBeAg-positive chronic hepatitis B who had serum HBsAg \u22651,000 IU/mL and HBV DNA <60 IU/mL after entecavir treatment.", "effective_dosage": "Telbivudine 600 mg/day; entecavir 0.5 mg/day.", "study_duration": "48 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:07.973366+00:00"}
{"study_id": 104426, "supplement_id": 863, "safety_score": "85", "efficacy_score": null, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the safety, tolerability, and pharmacokinetics of oral lucerastat in healthy male subjects.", "results_summary": "The study found that lucerastat was well tolerated with no severe or serious adverse events, though elevated ALT values were observed in the 500 mg dose cohort. No clinically relevant abnormalities in vital signs or electrocardiograms were reported.", "population_specificity": "Healthy male subjects", "effective_dosage": "Single doses of 100, 300, 500, or 1000 mg; multiple doses of 200, 500, or 1000 mg twice daily", "study_duration": "Single-dose study and 7 consecutive days for multiple-dose study", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:08.642269+00:00"}
{"study_id": 104427, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to analyze the relationship between non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome comorbidities, including alanine aminotransferase levels, in morbidly obese patients.", "results_summary": "The study found that altered LDL cholesterol and glycated hemoglobin levels were significantly associated with NAFLD, but alanine aminotransferase levels were not highlighted as a primary outcome.", "population_specificity": "Morbidly obese patients (74 women, 8 men) undergoing preoperative evaluation for bariatric surgery.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:10.369023+00:00"}
{"study_id": 104428, "supplement_id": 863, "safety_score": "24", "efficacy_score": 15, "quality_score": 65, "study_goal": "The researchers evaluated the safety and efficacy of BKM120 (a PI3K inhibitor) in patients with advanced or recurrent endometrial carcinoma, noting adverse effects including increased alanine aminotransferase levels.", "results_summary": "BKM120 showed minimal antitumour activity and an unfavourable safety profile, with significant toxicities such as increased alanine aminotransferase (24% grade \u22653 AEs). The trial was stopped early due to toxicity.", "population_specificity": "Patients with advanced or recurrent endometrial carcinoma (median age 67 years).", "effective_dosage": "Initially 100 mg/day, later reduced to 60 mg/day due to toxicity.", "study_duration": "Not explicitly stated in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:11.489986+00:00"}
{"study_id": 104429, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy and safety of entecavir (ETV) and lamivudine (LAM) in treating chronic HBV-related acute exacerbation (AE) and acute-on-chronic liver failure (ACLF), including their effects on serum alanine aminotransferase normalization.", "results_summary": "ETV and LAM showed similar short-term and long-term mortality rates in patients with chronic HBV-related AE, but ETV demonstrated superior long-term outcomes in ACLF patients, along with better virological and biochemical responses, including higher serum alanine aminotransferase normalization rates.", "population_specificity": "Patients with chronic HBV-related acute exacerbation (AE) with or without acute-on-chronic liver failure (ACLF).", "effective_dosage": "Not specified", "study_duration": "Short-term (within 4 months) and long-term (beyond 4 months) follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:14.263360+00:00"}
{"study_id": 104430, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to define key eligibility criteria and stopping rules for clinical trials involving healthy subjects, including considerations for alanine aminotransferase (ALT) levels in trials with new or clinically established investigational medicinal products (IMPs).", "results_summary": "The study established that ALT levels should not exceed the upper limit of normal (ULN) in first-in-human (FIH) trials, while slight elevations (10% above ULN) may be acceptable for trials with clinically established IMPs without known hepatotoxicity. Normal renal function was deemed essential for any clinical trial in healthy subjects.", "population_specificity": "Healthy subjects in clinical trials, with input from stakeholders in the pharmaceutical industry, contract research organizations, academia, ethics committees, and competent authorities.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:14.353724+00:00"}
{"study_id": 104432, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of \u03c9-3 PUFA supplementation, including its impact on alanine aminotransferase (ALT), in improving liver steatosis and function in children with NAFLD.", "results_summary": "PUFA supplementation significantly improved hepatic steatosis grade on ultrasound and liver functions, including ALT levels, without significant heterogeneity among studies.", "population_specificity": "Children and adolescents with non-alcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:15.194870+00:00"}
{"study_id": 104431, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 45, "study_goal": "The researchers aimed to evaluate the efficacy and safety of low-dose erlotinib (25 mg/day) as maintenance treatment after platinum doublet chemotherapy in NSCLC patients with EGFR mutation, not specifically Alanine.", "results_summary": "The study was stopped early due to poor accrual, but partial response was observed in 56% of patients, with median PFS of 14.9 months. Toxicities were generally mild, with no treatment-related deaths.", "population_specificity": "EGFR-mutation-positive NSCLC patients (n=11; median age 72 years; PS 0-3) who did not progress after first-line platinum-doublet chemotherapy.", "effective_dosage": "25 mg/day erlotinib (not Alanine).", "study_duration": "Until disease progression (median PFS 14.9 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:15.644979+00:00"}
{"study_id": 104433, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the immunogenicity and efficacy of modified immunotoxins (including HA22-LR-LO10) using alanine scanning mutagenesis to reduce B-cell epitopes while retaining cytotoxic activity.", "results_summary": "The study found that alanine scanning mutagenesis successfully identified and removed human-specific B-cell epitopes, resulting in immunotoxins (e.g., HA22-LR-LO10) with low immunogenicity and high cytotoxic and antitumor activity.", "population_specificity": "B-cell malignancies (in vitro and murine models, with human antisera reactivity tested).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:16.244049+00:00"}
{"study_id": 104435, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The study aimed to evaluate factors influencing outcomes in patients with postneurosurgical meningitis caused by A. baumannii and Enterobacteriaceae, including the role of alanine aminotransferase elevation.", "results_summary": "The study found that alanine aminotransferase elevation was significantly higher in patients with A. baumannii meningitis compared to those with Enterobacteriaceae meningitis, but it did not affect 30-day mortality.", "population_specificity": "Patients over 16 years old with post-surgical meningitis caused by A. baumannii or Enterobacteriaceae.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:18.612071+00:00"}
{"study_id": 104434, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of switching from entecavir (ETV) to pegylated interferon-\u03b1-2a (PegIFN\u03b1-2a) in chronic hepatitis B (CHB) patients who had previously responded to nucleos(t)ide analog (NA) treatment.", "results_summary": "The study found that switching to PegIFN\u03b1-2a resulted in a greater decrease in hepatitis B surface antigen (HBsAg) levels compared to continued ETV treatment, suggesting improved virological and serological responses. The treatment was concluded to be highly potent and safe for termination.", "population_specificity": "Chronic hepatitis B (CHB) patients who had received entecavir (ETV) for at least 48 weeks with controlled viral load and liver enzyme levels.", "effective_dosage": "0.5 mg daily ETV for 48 weeks (prior to switch to PegIFN\u03b1-2a).", "study_duration": "48 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:19.533906+00:00"}
